Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al > Documents

Date Field	Doc. No.	Description (Pages)
Oct 26, 2022	597	SO ORDERED, re 595 Stipulated Consent Judgment and Order (Apotex Inc. and Apotex Corp.). Signed by Judge Leonard P. Stark on 10/26/22. (ntl) (Entered: 10/26/2022) (2)
Oct 26, 2022	598	SO ORDERED, re 596 STIPULATION of Dismissal Without Prejudice (Defendants Apotex PharmaChem Inc. and Signa S.A. de C.V.). Signed by Judge Leonard P. Stark on 10/26/22. (ntl) (Entered: 10/26/2022) (2)
Oct 26, 2022	599	Report to the Commissioner of Patents and Trademarks. (ntl) (Entered: 10/26/2022) (3)
Oct 25, 2022	596	STIPULATION of Dismissal Without Prejudice (Defendants Apotex PharmaChem Inc. and Signa S.A. de C.V.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/25/2022) (2)
Oct 24, 2022	595	PROPOSED CONSENT JUDGMENT AND INJUNCTION (Apotex Inc. and Apotex Corp.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/24/2022) (2)
Oct 21, 2022	594	ORAL ORDER: At the request of the parties, the trial scheduled to begin today is CANCELLED. The parties shall submit a joint status report on October 31. ORDERED by Judge Leonard P. Stark on 10/21/22. (ntl) (Entered: 10/21/2022) (0)
Oct 20, 2022	590	ORAL ORDER: Having reviewed the parties' most recent status report, IT IS HEREBY ORDERED that each side will be allocated fifteen (15 hours) for its trial presentation. ORDERED by Judge Leonard P. Stark on 10/20/22. (ntl) (Entered: 10/20/2022) (0)
Oct 20, 2022	591	PROPOSED CONSENT JUDGMENT AND INJUNCTION (Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/20/2022) (2)
Oct 20, 2022	592	[SEALED] Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding Trial. (Balick, Steven) (Entered: 10/20/2022) (0)
Oct 20, 2022	593	SO ORDERED, re 591 STIPULATED CONSENT JUDGMENT AND INJUNCTION (Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) Party Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Ltd. terminated. Attorney Edward D. Pergament; Dmitry V. Shelhoff; Kenneth S. Canfield and Kenneth Laurence Dorsney terminated. Signed by Judge Leonard P. Stark on 10/20/22. (ntl) (Entered: 10/20/2022) (2)
Oct 19, 2022	587	MOTION for Pro Hac Vice Appearance of Attorney Julia S. Kim - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth) (Entered: 10/19/2022) (3)
Oct 19, 2022	588	STIPULATION Seeking Consolidation of Actions, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/19/2022) (3)
Oct 19, 2022	589	Joint STATUS REPORT by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/19/2022) (8)
Oct 12, 2022	586	STIPULATION Seeking to Further Extend the Joint Status Report Deadline, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/12/2022) (2)
Oct 7, 2022	585	STIPULATION TO EXTEND TIME to file Joint Status Report to October 12, 2022 - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) (Entered: 10/07/2022) (2)
Oct 5, 2022	584	[SEALED] Transcript of Pretrial Conference held on 9/30/2022 before Judge Leonard P. Stark. (nmg) (Entered: 10/05/2022) (0)
Oct 4, 2022	583	SO ORDERED, re 582 Stipulated Consent Judgment and Injunction -- Party MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc. terminated. Attorney Neal Seth; Teresa M. Summers; Alexander B. Owczarczak and John M. Seaman terminated. Signed by Judge Leonard P. Stark on 10/4/22. (ntl) (Entered: 10/04/2022) (2)
Oct 3, 2022	582	PROPOSED CONSENT JUDGMENT AND INJUNCTION (MSN Laboratories Pvt. Ltd. and MSN Pharmaceuticals Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 10/03/2022) (2)
Sep 30, 2022	581	ORAL ORDER: Based on the statements by the parties in Court today, IT IS HEREBY ORDERED that each side will be allocated eighteen (18) hours for trial. IT IS FURTHER ORDERED that a joint status report is due on October 7, 2022. ORDERED by Judge Leonard P. Stark on 9/30/22. (ntl) (Entered: 09/30/2022) (0)
Sep 27, 2022	580	ORAL ORDER: Having reviewed the parties' submissions relating to Plaintiffs' motion in limine to preclude the admission of, and Defendants' reliance on, non-prior art documents in Defendants' obviousness challenge (see, e.g., D.I. 576 Ex. 16), IT IS HEREBY ORDERED that Plaintiffs' motion is DENIED. Even non-prior art documents may, under certain circumstances, be probative of issues relating to obviousness, including the state of the art, selection of a lead compound, and motivation to combine, particularly to the extent the documents show what was known at the time of the alleged invention. See generally In re Copaxone Consolidated Cases, 906 F.3d 1013, 1030 (Fed. Cir. 2018) ("The district court did not use [a particular reference] as invalidating prior art, but instead as evidence of a POSITA's motivations and expectations when reading the prior art at the time of the invention."). As the Court will be presiding over a bench trial - and one in which time limits are imposed - and for the additional reasons also set out in this Order, the risks addressed in Federal Rule of Evidence 403 do not substantially outweigh the probative value of the challenged evidence. Defendants will not be permitted to rely on the two references (Kinghorn 2005 and Kikuchi 2021) as the basis for the Court to find a prior art disclosure of any element of a claim alleged to be invalid as obvious (nor does it appear Defendants intend to do so). The Court is also not persuaded that 35 U.S.C. Section 103 requires the exclusion of Kikuchi 2021 based on it reflecting the thought process of the inventors (though the Court agrees it cannot invalidate any patent claim based on the inventor's own path). See Otsuka Pharm. Co., Ltd. v. Sandoz, Inc., 678 F.3d 1280, 1296 (Fed. Cir. 2012). IT IS FURTHER ORDERED that the pretrial conference on Friday, September 30 will begin at 2:00 p.m. (not 3:00 p.m. as previously ordered) in Courtroom 6B. ORDERED by Judge Leonard P. Stark on 9/27/22. (ntl) (Entered: 09/27/2022) (0)
Sep 26, 2022	578	REDACTED VERSION of 572 Proposed Pretrial Order (Volume I of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1-9)(Mayo, Andrew) (Entered: 09/26/2022) (Main Document) (28)
Sep 26, 2022	579	REDACTED VERSION of 573 Proposed Pretrial Order (Volume II of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 10-16)(Mayo, Andrew) (Entered: 09/26/2022) (Main Document) (1)
Sep 26, 2022	579	REDACTED VERSION of 573 Proposed Pretrial Order (Volume II of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 10-16)(Mayo, Andrew) (Entered: 09/26/2022) (Exhibit 10-16) (30)
Sep 26, 2022	578	REDACTED VERSION of 572 Proposed Pretrial Order (Volume I of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1-9)(Mayo, Andrew) (Entered: 09/26/2022) (Exhibit 1-9) (30)
Sep 21, 2022	575	MEMORANDUM ORDER re 554 MOTION to Preclude the Testimony of Jeffrey Aube, Ph.D. filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S is DENIED. Signed by Judge Leonard P. Stark on 9/21/22. (ntl) (Entered: 09/21/2022) (4)
Sep 21, 2022	576	SO ORDERED, re 574 Stipulated Consent Judgment and Injunction -- Party Optimus Pharma Pvt. Ltd. terminated. Attorney Stamatios Stamoulis; Tedd W. Van Buskirk; Richard Charles Weinblatt; Ronald M. Daignault and Richard Juang terminated. Signed by Judge Leonard P. Stark on 9/21/22. (ntl) (Entered: 09/21/2022) (2)
Sep 21, 2022	577	NOTICE OF SERVICE of Defendants' Joint 282 Notice filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth) (Entered: 09/21/2022) (2)
Sep 20, 2022	574	PROPOSED CONSENT JUDGMENT AND INJUNCTION (Optimus Pharma Pvt. Ltd.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 09/20/2022) (2)
Sep 16, 2022	572	[SEALED] Proposed Pretrial Order (Volume I of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1-9 (Volume I of II))(Mayo, Andrew) (Attachment 1 replaced on 9/20/2022) (smg). (Entered: 09/16/2022) (0)
Sep 16, 2022	573	[SEALED] Proposed Pretrial Order (Volume II of II) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 10-16 (Volume II of II))(Mayo, Andrew) (Entered: 09/16/2022) (0)
Sep 14, 2022	571	REDACTED VERSION of 568 Reply Brief by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit I-K)(Balick, Steven) Modified on 9/14/2022 (srs). (Entered: 09/14/2022) (Main Document) (14)
Sep 14, 2022	571	REDACTED VERSION of 568 Reply Brief by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit I-K)(Balick, Steven) Modified on 9/14/2022 (srs). (Entered: 09/14/2022) (Exhibit I-K) (30)
Sep 8, 2022	569	[SEALED] PROPOSED CONSENT JUDGMENT AND INJUNCTION (Prinston Pharmaceutical Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 09/08/2022) (0)
Sep 8, 2022	570	REDACTED VERSION of 569 Proposed Consent Judgment and Injunction (Prinston Pharmaceutical Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 09/08/2022) (2)
Sep 7, 2022	566	STIPULATION of Dismissal Without Prejudice (Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 09/07/2022) (2)
Sep 7, 2022	567	SO ORDERED, re 566 Stipulation of Dismissal -- Party Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. terminated. Attorney Timothy H. Kratz; R. Touhey Myer; George J. Barry, III and Michael P. Hogan terminated. Signed by Judge Leonard P. Stark on 9/7/22. (ntl) (Entered: 09/07/2022) (2)
Sep 7, 2022	568	[SEALED] REPLY BRIEF re 554 MOTION to Preclude the Testimony of Jeffrey Aube, Ph.D. filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit I-K)(Balick, Steven) (Entered: 09/07/2022) (0)
Aug 31, 2022	564	SO ORDERED, re 563 Stipulated Dismissal -- Party Sandoz Inc. terminated. Attorney Mark H. Remus; Robert M. Vrana; Alexis White; Samantha G. Wilson; Anne Shea Gaza and Laura A. Lydigsen terminated. Signed by Judge Leonard P. Stark on 8/31/22. (ntl) (Entered: 08/31/2022) (2)
Aug 31, 2022	565	[SEALED] ANSWERING BRIEF in Opposition re 554 MOTION to Preclude the Testimony of Jeffrey Aube, Ph.D. filed by Prinston Pharmaceutical Inc..Reply Brief due date per Local Rules is 9/7/2022. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G)(Weinblatt, Richard) (Entered: 08/31/2022) (0)
Aug 30, 2022	563	STIPULATION of Dismissal Without Prejudice (Sandoz Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/30/2022) (2)
Aug 29, 2022	562	ORAL ORDER: Having reviewed the joint status report of August 26 (D.I. 561), IT IS HEREBY ORDERED that the parties will be allocated no more than twenty (20) hours per side for their trial presentations, and that number may be reduced after the Court reviews the pretrial order and/or conducts the pretrial conference. IT IS FURTHER ORDERED that trial will be held at some or all of the following times, subject to the parties' time limits: (a) Friday, October 21 from 8:30 a.m. to 6:30 p.m.; (b) Monday, October 24 from 8:30 a.m. to 6:30 p.m.; (c) Tuesday, October 25 from 8:30 a.m. to 6:30 p.m.; (d) Wednesday, October 26 from 8:30 a.m. to 12:30 p.m.; (e) Thursday, November 17 from 8:30 a.m. to 6:30 p.m.; and (f) Friday, November 18 from 8:30 a.m. to 6:30 p.m. The parties shall include their updated proposal(s) for the post-trial briefing schedule in the pretrial order and they should aim to work cooperatively to propose a schedule that will provide the Court sufficient time to write an opinion while also minimizing the risk that preliminary injunction practice will be required. All remaining dates and deadlines in the Courts prior scheduling orders (including D.I. 557) remain in effect. Ordered by Judge Leonard P. Stark on 8/29/2022. (etg) (Entered: 08/29/2022) (0)
Aug 26, 2022	561	Joint STATUS REPORT by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/26/2022) (3)
Aug 24, 2022	559	SO ORDERED, re 558 Stipulated Consent Judgment and Injunction -- Party Zydus Lifesciences Limited and Zydus Pharmaceuticals (USA) Inc. terminated. Attorney Michael J. Gaertner; Myoka Kim Goodin; Pilar Gabrielle Kraman; Zhibin Li; Wasim K. Bleibel and Leah Brackensick terminated. Signed by Judge Leonard P. Stark on 8/24/22. (ntl) (Entered: 08/24/2022) (2)
Aug 24, 2022	560	REDACTED VERSION of 555 Opening Brief in Support, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew) (Entered: 08/24/2022) (30)
Aug 23, 2022	558	PROPOSED CONSENT JUDGMENT AND INJUNCTION (Zydus Pharmaceuticals USA Inc. and Zydus Lifesciences Limited), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/23/2022) (2)
Aug 22, 2022	557	ORAL ORDER: Having reviewed the parties' joint status report of August 19 (D.I. 556), and given circumstances relating to the Court's calendar, IT IS HEREBY ORDERED that the following schedule shall govern proceedings going forward: (1) trial will be held at some or all of the following times: (a) Friday, October 21 from 8:30 a.m. 6:30 p.m.; (b) Monday, October 24 from 8:30 a.m. 6:30 p.m.; (c) Tuesday, October 25 from 8:30 a.m. to 6:30 p.m.; (d) Wednesday, October 26 from 8:30 a.m. to 12:30 p.m.; and, to the extent necessary, (e) any or all of the following days in November: 7, 8, 9, 14, 15, 16, 17, 18, 21, 22, 28, and 29, with specific days and times to be determined (see below); (2) the deadlines for the preparation and filing of the proposed pretrial order (due September 16) are unchanged; (3) the pretrial conference will be held, as currently scheduled, on September 30 at 3:00 p.m.; and (4) the Court will determine a reasonable and appropriate number of hours to be allocated to each side for conducting its trial presentation, at or around the time of the pretrial conference; the parties are advised that their current request of 25 hours per side would make for an unusually (though not unprecedentedly) long trial of this kind and, should they continue to request so much time, they will need to provide a detailed justification. IT IS FURTHER ORDERED that the parties shall meet and confer and, no later than August 26, submit another joint status report advising the Court of their preferences as to (i) which November days and times should be set aside for potential trial, (ii) when they would propose post-trial briefing be submitted (based on their preferred trial end date), and (iii) why they believe so many hours will be required for trial. Ordered by Judge Leonard P. Stark on 8/22/2022. (etg) (Entered: 08/22/2022) (0)
Aug 19, 2022	556	Letter to The Honorable Leonard P. Stark from Andrew C. Mayo regarding joint status report. (Mayo, Andrew) (Entered: 08/19/2022) (2)
Aug 17, 2022	552	ORAL ORDER: Having reviewed the parties' proposed stipulation (D.I. 551), IT IS HEREBY ORDERED that the stipulation is GRANTED IN PART and DENIED IN PART such that the joint status report shall be filed no later than 10:00 a.m. on Friday, August 19. ORDERED by Judge Leonard P. Stark on 8/17/22. (ntl) (Entered: 08/17/2022) (0)
Aug 17, 2022	553	SO ORDERED, re 549 Stipulation of Dismissal -- Party Raks Pharma Pvt. Ltd., Amneal Pharmaceuticals Company GmbH and Amneal Pharmaceuticals LLC terminated. Signed by Judge Leonard P. Stark on 8/17/22. (ntl) (Entered: 08/17/2022) (2)
Aug 17, 2022	554	MOTION to Preclude the Testimony of Jeffrey Aube, Ph.D. - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/17/2022) (3)
Aug 17, 2022	555	[SEALED] OPENING BRIEF in Support re 554 MOTION to Preclude the Testimony of Jeffrey Aube, Ph.D. filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..Answering Brief/Response due date per Local Rules is 8/31/2022. (Attachments: # 1 Exhibit A-H)(Balick, Steven) (Entered: 08/17/2022) (0)
Aug 16, 2022	548	REDACTED VERSION of 544 Letter by Sandoz Inc.. (Vrana, Robert) (Entered: 08/16/2022) (6)
Aug 16, 2022	549	STIPULATION of Dismissal Without Prejudice (Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH, Raks Pharma Pvt. Ltd.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/16/2022) (2)
Aug 16, 2022	550	NOTICE of Appearance by Kaan Ekiner on behalf of Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. (Ekiner, Kaan) (Entered: 08/16/2022) (1)
Aug 16, 2022	551	STIPULATION Seeking to Extend the Deadline by which the Interim Status Report is Due, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/16/2022) (4)
Aug 15, 2022	547	REDACTED VERSION of 543 Letter, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1)(Balick, Steven) (Entered: 08/15/2022) (Main Document) (2)
Aug 15, 2022	547	REDACTED VERSION of 543 Letter, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1)(Balick, Steven) (Entered: 08/15/2022) (Exhibit 1) (2)
Aug 11, 2022	546	ORAL ORDER: Having reviewed the parties' letters regarding a discovery dispute (see D.I. 543, 544), IT IS HEREBY ORDERED that Plaintiffs' request that MSN and Sandoz be required to produce Dr. Reus for an in-person deposition is DENIED. Virtual depositions have been permitted for fact discovery in this case due to the ongoing global health crisis. (See, e.g., D.I. 34 at 13-14) Defendants represent that their expert is at some greater-than-average risk of adverse health consequences were he to contract Covid and Plaintiffs fail to identify any meaningful prejudice that would result from conducting his deposition virtually. IT IS FURTHER ORDERED that the discovery teleconference set for 12:00 pm on August 12, 2022 is CANCELLED. ORDERED by Judge Leonard P. Stark on 8/11/22. (ntl) (Entered: 08/11/2022) (0)
Aug 10, 2022	545	REDACTED VERSION of 541 Letter by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven) (Entered: 08/10/2022) (2)
Aug 9, 2022	544	[SEALED] Letter to The Honorable Leonard P. Stark from Robert M. Vrana regarding Discovery Dispute - re 542 Order Setting Teleconference,,. (Attachments: # 1 Exhibit A)(Vrana, Robert) (Entered: 08/09/2022) (0)
Aug 8, 2022	543	[SEALED] Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding Plaintiffs' Opening Letter Brief Concerning the Discovery Teleconference on August 12, 2022 at 12:00 p.m. (D.I. 542). (Attachments: # 1 Exhibit 1)(Balick, Steven) (Entered: 08/08/2022) (0)
Aug 5, 2022	542	ORAL ORDER: IT IS HEREBY ORDERED that a discovery teleconference is set for August 12, 2022 beginning at 12:00 p.m. The parties shall arrange for the teleconference and shall provide the Court with the call-in information. IT IS FURTHER ORDERED that not later than August 8, 2022, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than August 9, 2022, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. ORDERED by Judge Leonard P. Stark on 8/5/22. (ntl) (Entered: 08/05/2022) (0)
Aug 3, 2022	541	[SEALED] Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding Request for the Scheduling of a Discovery Teleconference. (Balick, Steven) (Entered: 08/03/2022) (0)
Jul 29, 2022	540	SO ORDERED (2) Docket Text: SO ORDERED, re [539] STIPULATED CONSENT JUDGMENT AND INJUNCTION (Lupin Limited and Lupin Pharmaceuticals, Inc.) -- Party Lupin Limited and Lupin Pharmaceuticals Inc. terminated. Attorney Aryeh N. Feinstein; Megan C. Haney; John C. Phillips, Jr; Carol M. Pitzel Cruz; William R. Zimmerman; David A. Bilson and Andrea L. Cheek terminated. Signed by Judge Leonard P. Stark on 7/29/22. (ntl)
Jul 28, 2022	537	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ivan T. Hofmann on July 29, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jul 28, 2022	538	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Victor L. Reus, M.D. filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jul 28, 2022	539	Proposed Consent Judgment (2) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Lupin Limited and Lupin Pharmaceuticals, Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jul 21, 2022	536	Redacted Document (2) Docket Text: REDACTED VERSION of [526] Stipulation by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jul 20, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [535] STIPULATION Seeking to Extend the Deadline to File a Redacted Public Version of D.I. 526 (Lupin Limited and Lupin Pharmaceuticals, Inc.) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 7/20/22. (ntl)
Jul 19, 2022	535	Stipulation (2) Docket Text: STIPULATION Seeking to Extend the Deadline to File a Redacted Public Version of D.I. 526 (Lupin Limited and Lupin Pharmaceuticals, Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jul 18, 2022	534	Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Bryan Roth, M.D., Ph.D. on July 27, 2022 filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd., Sandoz Inc..(Vrana, Robert)
Jul 15, 2022	531	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anthony J. Rothschild, M.D. on July 22, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 15, 2022	532	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Fernando J. Muzzio, Ph.D. on July 25, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 15, 2022	533	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of John C. Jarosz on July 21, 2022 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Myer, R.)
Jul 14, 2022	528	Notice to Take Deposition (4) Docket Text: NOTICE to Take Deposition of Stephen R. Byrn, Ph.D. on July 20, 2022 filed by Apotex Corp., Apotex Inc., Signa S.A. de C.V..(Francella, Thomas)
Jul 14, 2022	529	Proposed Consent Judgment (2) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Ajanta Pharma Ltd.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jul 14, 2022	530	SO ORDERED (2) Docket Text: SO ORDERED, re [529] Stipulated Consent Judgment and Injunction -- Party Ajanta Pharma Ltd. terminated. Attorney Stamatios Stamoulis; Tedd W. Van Buskirk; Richard Charles Weinblatt; Ronald M. Daignault and Richard Juang terminated. Signed by Judge Leonard P. Stark on 7/14/22. (ntl)
Jul 13, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [526] Stipulation filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 7/13/22. (ntl)
Jul 13, 2022	527	Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Lisbeth Illum, Ph.D. on July 20, 2022 filed by Ajanta Pharma Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc..(Weinblatt, Richard)
Jul 12, 2022	525	SO ORDERED (2) Docket Text: SO ORDERED, re [524] Stipulated Consent Judgment and Injunction -- Party Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd. terminated. Attorney Kenneth Laurence Dorsney terminated. Signed by Judge Leonard P. Stark on 7/12/22. (ntl)
Jul 11, 2022	521	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Michael M. Crowley, Ph.D. on July 28, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 11, 2022	522	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Richard C. Moreton, Ph.D. on July 26, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 11, 2022	523	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jeffrey Aube, Ph.D on July 21, 2022 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 11, 2022	524	Proposed Consent Judgment (2) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Jul 8, 2022	520	Notice to Take Deposition (5) Docket Text: NOTICE to Take Deposition of Christopher Correll, M.D. on July 13, 2022 filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Jun 30, 2022	519	Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Kayvon M. Ghayoumi as co-counsel.. (Balick, Steven)
Jun 28, 2022	517	Notice to Take Deposition (6) Docket Text: NOTICE to Take Deposition of Simon Ward, Ph.D. on June 30, 2022 filed by Zydus Lifesciences Limited, Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar)
Jun 28, 2022	518	SO ORDERED (3) Docket Text: SO ORDERED, re [516] Stipulation and Order of Dismissal -- Party Alkem Laboratories Ltd. terminated. Attorney Lauren M. Lesko; William A. Rakoczy; Elizabeth A. DeFelice and Dominick T. Gattuso terminated. Signed by Judge Leonard P. Stark on 6/28/22. (ntl)
Jun 27, 2022	516	Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal (Alkem Laboratories Ltd.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jun 8, 2022	515	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Supplemental Sur-Reply Expert Report of Lisbeth Illum, Ph.D. filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jun 6, 2022	514	SO ORDERED (5) Docket Text: SO ORDERED, re [513] STIPULATED ORDER to amend deadlines in scheduling order -- Status Report due by 8/16/2022. Oral argument scheduled for 7/12/22 is cancelled. Briefing on Daubert motions due 8/17/22, 8/31/22, and 9/7/22. Signed by Judge Leonard P. Stark on 6/6/22. (ntl)
Jun 3, 2022	513	Stipulation (5) Docket Text: STIPULATION to amend deadlines in scheduling order, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
May 31, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [512] STIPULATION Seeking to Extend the Deadline by which an Interim Status Report is Due filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 5/31/22. (ntl)
May 27, 2022	512	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which an Interim Status Report is Due, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
May 24, 2022	N/A	Scheduling Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' letter of May 6 (D.I. 504), IT IS HEREBY ORDERED that: (1) it is currently anticipated that Judge Stark will continue to preside over these consolidated cases (including the proceedings scheduled by the instant order, which will be conducted in the J. Caleb Boggs Federal Building in Wilmington, Delaware); (2) a hearing on pending motions will be held on July 12 at 10:00 a.m. (and the parties shall, no later than July 1, submit a joint letter indicating the amount of time they are requesting for oral argument); (3) the proposed pretrial order is due on September 16 (any remaining disputes relating to order of presentation shall be identified in the PTO); (4) the pretrial conference will be held on September 30 at 3:00 p.m.; and (5) a bench trial will be held on October 17-21 and 24-25, subject to time limits the Court will provide at or around the time of the pretrial conference. ORDERED by Judge Leonard P. Stark on 5/24/22. (ntl)
May 19, 2022	510	SO ORDERED (2) Docket Text: SO ORDERED, re [509] Stipulated Consent Judgment and Injunction -- Party Alembic Pharmaceuticals Inc. and Alembic Pharmaceuticals Ltd. terminated. Attorney Robert W. Stout; Dennies Varughese, Pharm.D; David Ellis Moore and Bindu Ann George Palapura terminated. Signed by Judge Leonard P. Stark on 5/19/22. (ntl)
May 18, 2022	509	Proposed Consent Judgment (2) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
May 16, 2022	507	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sur-Reply Expert Report of Christoph U. Correll, M.D., Sur-Reply Expert Report of Lisbeth Illum, Ph.D. and Sur-Reply Expert Report of John Jarosz (Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
May 16, 2022	508	Notice of Service (4) Docket Text: NOTICE OF SERVICE of Sur-Reply Expert Report of Christoph U. Correll, M.D., Sur-Reply Expert Report of Lisbeth Illum, Ph.D., Sur-Reply Expert Report of Bryan Roth, M.D., Ph.D. and Sur-Reply Expert Report of John Jarosz (All Defendants Except Apotex Inc., Apotex Corp., Apotex Pharmachem Inc., and Signa S.A. de C.V.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
May 11, 2022	506	SO ORDERED (3) Docket Text: SO ORDERED, re [505] Stipulated Consent Judgment and Injunction filed by Honour Lab Ltd. -- Party Honour Lab Ltd. terminated. Signed by Judge Leonard P. Stark on 5/11/22. (ntl)
May 10, 2022	505	Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT as to Defendant Honour Lab Ltd. by Honour Lab Ltd.. (Hitch, Cortlan)
May 6, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [503] STIPULATION TO EXTEND TIME for the parties to advise the court their availability and preference for trial schedule to May 6, 2022 filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Macleods Pharma USA, Inc., Hetero Labs Ltd., Hetero USA Inc., Macleods Pharmaceuticals Ltd., Hetero Labs Ltd. Unit-V, Honour Lab Ltd., Hetero Drugs Ltd. Signed by Judge Leonard P. Stark on 5/6/22. (ntl)
May 6, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [502] STIPULATED CONSENT JUDGMENT AND INJUNCTION (Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA, Inc., Hetero Drugs Ltd.) -- Party Hetero Labs Ltd. Unit-V, Hetero USA Inc., Hetero Drugs Ltd. and Hetero Labs Ltd. terminated. Signed by Judge Leonard P. Stark on 5/6/22. (ntl)
May 6, 2022	504	Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Andrew C. Mayo regarding joint status report. (Mayo, Andrew)
May 4, 2022	502	Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA, Inc., Hetero Drugs Ltd.) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
May 4, 2022	503	Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME for the parties to advise the court their availability and preference for trial schedule to May 6, 2022 - filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
May 3, 2022	500	Main Document (5) Docket Text: MOTION [UNOPPOSED MOTION TO CHANGE NAME OF DEFENDANT CADILA HEALTHCARE LIMITED TO ZYDUS LIFESCIENCES LIMITED] - filed by Cadila Healthcare Ltd.. (Attachments: # (1) Text of Proposed Order)(Kraman, Pilar)
May 3, 2022	500	Text of Proposed Order (2)
May 3, 2022	501	SO ORDERED (2) Docket Text: ORDER GRANTING [500] UNOPPOSED MOTION TO CHANGE NAME OF DEFENDANT CADILA HEALTHCARE LIMITED TO ZYDUS LIFESCIENCES LIMITED filed by Cadila Healthcare Ltd. Signed by Judge Leonard P. Stark on 5/3/22. (ntl)
May 2, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [498] STIPULATED ORDER TO EXTEND TIME for the parties to advise the Court of their availability and preference for the trial schedule to May 4, 2022 filed by Biophore India Pharmaceuticals Private Ltd., Hetero Labs Ltd. Unit-V, Zenara Pharma Private Ltd., Hetero Labs Ltd., Hetero Drugs Ltd.; [499] STIPULATED ORDER Seeking to Extend the Deadline by which Plaintiffs' Surreply Expert Report is Due filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 5/2/22. (ntl)
Apr 29, 2022	498	Stipulation to EXTEND Time (6) Docket Text: STIPULATION TO EXTEND TIME for the parties to advise the Court of their availability and preference for the trial schedule to May 4, 2022 - filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Apr 29, 2022	499	Stipulation (6) Docket Text: STIPULATION Seeking to Extend the Deadline by which Plaintiffs' Surreply Expert Report is Due, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Apr 27, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [459] [SEALED] Joint STIPULATION filed by Teva Pharmaceuticals USA Inc. Signed by Judge Leonard P. Stark on 4/27/22. (ntl)
Apr 27, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [464] Stipulated Consent Judgment and Injunction (Teva) -- Party Teva Pharmaceuticals USA Inc. terminated. Attorney Nathan Roger Hoeschen; Elizabeth J. Holland; Karen Elizabeth Keller; Emily L. Rapalino; Srikanth K. Reddy; Naomi L. Birbach and Jacqueline Genovese Bova terminated. Signed by Judge Leonard P. Stark on 4/27/22. (ntl)
Apr 27, 2022	497	SO ORDERED (6) Docket Text: SO ORDERED, re [463] STIPULATED ORDER to Amend Scheduling Order filed by Amneal Pharmaceuticals LLC. Signed by Judge Leonard P. Stark on 4/27/22. (ntl)
Apr 25, 2022	N/A	Case Assigned/Reassigned (0) Docket Text: Case Reassigned to Judge Leonard P. Stark of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (LPS) after the case number on all documents filed. (ntl)
Apr 25, 2022	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' submissions (see, e.g., D.I. 460, 461, 465, 467, 471, 472), the Court finds there is no actual dispute as to the earliest date the FDA may approve one or more of Defendants' ANDAs. That date is January 10, 2023. (See, e.g., D.I. 465 at 6; D.I. 472 at 1) At least two Defendants have already taken steps to ready their ANDAs for final approval by on or around January 10, 2023. Regardless of how many other filers may do the same, the Court believes that the most prudent course of action is to hold trial at a time that would make it possible to resolve the parties' disputes on the merits, without need for preliminary injunction practice, by on or around January 10, 2023. The Court envisions setting an accelerated post-trial briefing schedule. Accordingly, IT IS HEREBY ORDERED that: (1) the pending dates (July 8, 2022 pretrial conference and July 25-August 2, 2022 trial) are VACATED; and (2) the parties shall meet and confer and file a joint status report, no later than April 29, 2022, advising the Court of their availability and preference for trial to be held on some or all of the following days: September 12-15, 19-22, 28-30; October 11-14, 17-21, 24-25, 2022. ORDERED by Judge Leonard P. Stark on 4/25/22. (ntl)
Apr 19, 2022	480	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendant Sandoz Inc.) and Reply Expert Report of Christoph U. Correll, M.D. (Defendant Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	481	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. and MSN Life Sciences Pvt. Ltd.) and Reply Expert Report of Christoph U. Correll, M.D. (Defendants MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. and MSN Life Sciences Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	482	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	483	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendant Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	484	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	485	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendant Optimus Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	486	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	487	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Prinston Pharmaceutical Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	488	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	489	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	490	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	491	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	492	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA, Inc., Hetero Drugs Ltd. and Honour Lab Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	493	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH and Raks Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	494	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Stephen R. Byrn, Ph.D. (Defendant Ajanta Pharma Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Apr 19, 2022	495	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Reply Expert Report of Anthony J. Rothschild, M.D.; 2) Reply Expert Report of Jeffrey Aub, Ph.D.; and 3) Reply Expert Report of Michael M. Crowley, Ph.D. filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd., Sandoz Inc..(Wilson, Samantha)
Apr 18, 2022	479	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Reply Expert Report of Ivan T. Hofmann filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Myer, R.)
Apr 6, 2022	474	Redacted Document (12) Docket Text: REDACTED VERSION of [467] Answering Brief in Opposition, by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC. (Vrana, Robert)
Apr 6, 2022	475	Redacted Document (27) Docket Text: REDACTED VERSION of [472] Reply Brief, by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC. (Vrana, Robert)
Apr 6, 2022	476	Redacted Document (9) Docket Text: REDACTED VERSION of [465] Memorandum in Opposition by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Apr 6, 2022	477	Redacted Document (8) Docket Text: REDACTED VERSION of [471] MEMORANDUM in Support by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Apr 6, 2022	478	Redacted Document (13) Docket Text: REDACTED VERSION of [473] Declaration of Tyler B. Latcham by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Apr 4, 2022	N/A	Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel)
Mar 31, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Main Document for D.I. [462] replaced per counsel's request. (srs)
Mar 30, 2022	468	Redacted Document (5) Docket Text: REDACTED VERSION of [459] Stipulation by Teva Pharmaceuticals USA Inc.. (DiBenedetto, Emily)
Mar 30, 2022	469	Redacted Document (9) Docket Text: REDACTED VERSION of [461] Opening Brief in Support by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Mar 30, 2022	470	Redacted Document (30) Docket Text: REDACTED VERSION of [462] Declaration, of Tyler B. Latcham by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Mar 29, 2022	466	Declaration (18) Docket Text: DECLARATION re [465] Memorandum in Opposition (Declaration of Tyler B. Latcham) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Mar 25, 2022	464	Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Mar 24, 2022	463	Stipulation (6) Docket Text: STIPULATION to Amend Scheduling Order by Amneal Pharmaceuticals LLC. (Vrana, Robert)
Mar 23, 2022	460	Main Document (12) Docket Text: OPENING BRIEF in Support [DEFENDANTS' OPENING BRIEF REGARDING THE EARLIEST DATE THAT THE FDA CAN APPROVE DEFENDANTS' ANDAs] re (D.I. 458) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..Answering Brief/Response due date per Local Rules is 4/6/2022. (Attachments: # (1) Exhibit A-D)(Kraman, Pilar)
Mar 23, 2022	460	Exhibit A-D (121)
Mar 14, 2022	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the joint status report filed on March 9 (see, e.g., C.A. No. 22-221 D.I. 8), IT IS HEREBY ORDERED that the parties shall submit the following, to assist the Court in resolving their dispute as to the earliest date the FDA may approve any ANDAs (January 10, 2023 or December 27, 2024), which has implications for the timing of the trial, which will likely be rescheduled from its current dates of July and August 2022: (i) on March 23, the parties shall file simultaneous opening briefs, not to exceed 20 pages per side (i.e., 20 in total for plaintiffs and 20 in total for defendants), setting out the arguments for their position on the date the FDA may approve any ANDAs; (ii) on March 29, the parties shall file answering briefs, not to exceed 10 pages per side; and (iii) on March 31, the parties shall file reply briefs, not to exceed 5 pages per side. ORDERED by Judge Leonard P. Stark on 3/14/22. Associated Cases: 1:19-cv-01938-LPS, 1:22-cv-00221-LPS (ntl)
Mar 10, 2022	457	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Expert Report of John Jarosz and Rebuttal Expert Reports for Christoph U. Correll, M.D., Lisbeth Illum, Ph.D., Brian Roth and Simon Ward filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Mar 9, 2022	456	Main Document (2) Docket Text: Joint STATUS REPORT by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit 1)(Mayo, Andrew)
Mar 9, 2022	456	Exhibit 1 (7)
Mar 8, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [451] STIPULATION TO EXTEND TIME for the parties to submit a joint status report to March 9, 2022 filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/8/22. (ntl)
Mar 8, 2022	455	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responsive Expert Report of Victor I. Reus, M.D. on behalf of Defendants Sandoz Inc., MSN Laboratories Pvt. Ltd., and MSN Pharmaceuticals Inc. filed by Sandoz Inc..(Wilson, Samantha)
Mar 7, 2022	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Notice of Service at D.I. 452 was removed from the docket per request of counsel. (ntl)
Mar 7, 2022	452	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Macleods' Responsive Expert Report of Alekha K. Dash regarding Noninfringement filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Mar 7, 2022	453	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Fernando J. Muzzio, Ph.D. (with Appendices A-F) [HIGHLY CONFIDENTIAL] filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Mar 7, 2022	454	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rebuttal Expert Report of Dr. Richard Christian Moreton, Ph.D. filed by Prinston Pharmaceutical Inc..(Weinblatt, Richard)
Mar 4, 2022	450	Redacted Document (5) Docket Text: REDACTED VERSION of (15 in 1:20-cv-01286-LPS, 447 in 1:19-cv-01938-LPS) Stipulation, SO ORDERED, by Alkem Laboratories Ltd.. (Gattuso, Dominick)
Mar 4, 2022	451	Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a joint status report to March 9, 2022 - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Mar 2, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [449] STIPULATION TO EXTEND TIME for the parties to submit a Joint Status Report pursuant to the Court's February 28, 2022 Order to March 4, 2022 filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd., Macleods Pharma USA, Inc., Hetero Labs Ltd., Hetero USA Inc., Macleods Pharmaceuticals Ltd., Hetero Labs Ltd. Unit-V, Honour Lab Ltd., Hetero Drugs Ltd. Signed by Judge Leonard P. Stark on 3/2/22. (ntl)
Mar 1, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01763-LPS, 446 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zydus). Signed by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01763-LPS (ntl)
Mar 1, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01286-LPS, 447 in 1:19-cv-01938-LPS) [SEALED] STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (Alkem). Signed by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01286-LPS (ntl)
Mar 1, 2022	449	Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME for the parties to submit a Joint Status Report pursuant to the Court's February 28, 2022 Order to March 4, 2022 - filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Feb 28, 2022	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that in anticipation of reassignment of these cases to another judge, the parties shall meet and confer and, no later than tomorrow, March 1, submit a joint status report (one that collectively addresses all of these related cases), advising the Court of the following (in addition to anything else the parties wish to report): (i) how many and which patents are at issue in any of these cases; (ii) how many applications or how many filers are at issue, in total, across these cases; (iii) how many contested infringement allegations remain to be litigated; (iv) how many invalidity issues are to be litigated; (v) when do any applicable stays (e.g., 30-month stay) expire; (vi) how long do the parties anticipate the upcoming bench trial to be; and (vii) how important is it that trial occur on or around July 25, 2022, as currently scheduled? ORDERED by Judge Leonard P. Stark on 2/28/22. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01286-LPS, 1:20-cv-01763-LPS, 1:22-cv-00221-LPS (ntl)
Feb 25, 2022	446	Stipulation (6) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zydus), by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Feb 22, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [445] STIPULATION Seeking to Extend Certain Deadlines filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 2/22/22. (ntl)
Feb 17, 2022	445	Stipulation (6) Docket Text: STIPULATION Seeking to Extend Certain Deadlines, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Feb 11, 2022	444	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Feb 8, 2022	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tedd W. Van Buskirk for Ajanta Pharma Ltd. and Optimus Pharma Pvt. Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Feb 4, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [443] MOTION for Pro Hac Vice Appearance of Attorney Tedd W. Van Buskirk filed by Optimus Pharma Pvt. Ltd., Ajanta Pharma Ltd. Signed by Judge Leonard P. Stark on 2/4/22. (ntl)
Feb 3, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [441] Stipulated Consent Judgment and Injunction -- Party Accord Healthcare Inc. terminated. Attorney Neal Seth; Teresa M. Summers; Alexander B. Owczarczak and John M. Seaman terminated. Signed by Judge Leonard P. Stark on 2/2/22. (ntl)
Feb 3, 2022	443	Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Tedd W. Van Buskirk - filed by Ajanta Pharma Ltd., Optimus Pharma Pvt. Ltd.. (Weinblatt, Richard)
Feb 2, 2022	442	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rahul Dabre on February 4, 2022 filed by Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Feb 1, 2022	441	Proposed Consent Judgment (2) Docket Text: PROPOSED CONSENT JUDGMENT AND INJUNCTION (Accord Healthcare Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jan 21, 2022	440	Stipulation (3) Docket Text: STIPULATION Between Plaintiffs and Defendant Teva Pharmaceuticals USA, Inc. Regarding Authenticity of Documents, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jan 18, 2022	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [422] STIPULATION and Order to Extend Time Seeking to Extend the Deadline for Plaintiffs' Opening Expert Reports with respect to Alembic only filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/18/22. (ntl)
Jan 18, 2022	423	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Opening Expert Report of Anthony J. Rothschild, M.D. (2) Opening Expert Report of Jeffrey Aube, Ph.D. (3) Opening Expert Report of Michael M. Crowley, Ph.D. filed by Teva Pharmaceuticals USA Inc..(Keller, Karen)
Jan 18, 2022	424	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA, Inc., Hetero Drugs Ltd. and Honour Lab Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	425	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. and MSN Life Sciences Pvt. Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendants MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. and MSN Life Sciences Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	426	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Alkem Laboratories Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendant Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	427	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Teva Pharmaceuticals USA, Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendant Teva Pharmaceuticals USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	428	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	429	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Prinston Pharmaceutical Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendant Prinston Pharmaceutical Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	430	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	431	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Sandoz Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendant Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	432	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	433	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	434	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendants Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	435	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Ajanta Pharma Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendant Ajanta Pharma Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	436	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Optimus Pharma Pvt. Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendant Optimus Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	437	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH and Raks Pharma Pvt. Ltd.) and Expert Report of Christoph U. Correll, M.D. (Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH and Raks Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	438	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report Of Stephen R. Byrn, Ph.D. (Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 18, 2022	439	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Expert Report of Stephen R. Byrn, Ph.D. (Defendant Accord Healthcare Inc.) and Expert Report of Christoph U. Correll, M.D. (Defendant Accord Healthcare Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jan 13, 2022	422	Stipulation (2) Docket Text: STIPULATION Seeking to Extend the Deadline for Plaintiffs' Opening Expert Reports, with respect to Alembic only, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jan 3, 2022	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the filings relating to the requests of the Summary Judgment Defendants and Apotex Defendants (collectively, "Moving Defendants") for leave to file motions for summary judgment of noninfringement of the '419 patent (see, e.g., D.I. 401, 403, 408, 409, 415, 416), IT IS HEREBY ORDERED that the Moving Defendants' requests are DENIED. It appears that the Moving Defendants have strong noninfringement positions - Plaintiffs concede the Moving Defendants do not literally infringe and it appears likely the Moving Defendants may prevail on their disclosure-dedication and/or prosecution history estoppel positions. While Plaintiffs are incorrect when they suggest that expert discovery is always required before a Court may resolve a doctrine of equivalents infringement claim involving the types of defenses raised by the Moving Defendants, the Moving Defendants are also incorrect when they suggest all the Court needs to do in this case is read the patent specification and prosecution history. In this case, the Court will find it helpful (and possibly necessary) to have the benefit of expert testimony in assessing what one of ordinary skill in the art would understand to have been disclosed in the specification but not claimed by the patentee, and in evaluating the parties' competing positions with respect to argument-based and amendment-based estoppel. Furthermore, under the totality of circumstances - including that trial on the '419 patent is going to be required with respect to at least the three defendant groups who are not Moving Defendants, that other patents are asserted against all Moving Defendants other than Apotex (thus requiring trial involving these defendants and other patents even if summary judgment on the '419 patent were to be granted to the Moving Defendants), and the reality that the Court's schedule will almost certainly make it unlikely the Court would rule on any summary judgment motion significantly in advance of the scheduled July 25 trial - it would not be a wise use of scarce judicial resources to grant the Moving Defendants the leave they seek. ORDERED by Judge Leonard P. Stark on 1/3/22. (ntl)
Dec 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (14 in 1:20-cv-01297-LPS, 420 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Amneal) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/28/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01297-LPS (ntl)
Dec 21, 2021	420	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Amneal), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Dec 20, 2021	419	Redacted Document (5) Docket Text: REDACTED VERSION of [416] Letter, by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V.. (Francella, Thomas)
Dec 17, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael P. Hogan for Aurobindo Pharma Ltd. and Aurobindo Pharma USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Dec 15, 2021	417	Redacted Document (30) Docket Text: REDACTED VERSION of [408] Letter by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Dec 15, 2021	418	Redacted Document (30) Docket Text: REDACTED VERSION of [409] Letter by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Dec 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [413] STIPULATION Regarding Infringement of Certain Asserted Patents and Claims (Zenara) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/14/21. (ntl)
Dec 13, 2021	414	Notice Requesting Removal of Co-Counsel (2) Docket Text: NOTICE requesting Clerk to remove Eric Levi as co-counsel. Reason for request: No longer with the firm Cozen O'Connor. (Francella, Thomas)
Dec 13, 2021	415	Letter (6) Docket Text: Joint Letter to The Honorable Leonard P. Stark from Anne Shea Gaza regarding Reply in Support of Certain Defendants' Request for Leave to File a Joint Motion for Summary Judgment of Noninfringement of the '419 Patent - re [409] Letter, [401] Letter. (Gaza, Anne)
Dec 10, 2021	413	Stipulation (3) Docket Text: STIPULATION Regarding Infringement of Certain Asserted Patents and Claims (Zenara), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Dec 9, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [407] STIPULATED ORDER Seeking to Extend the Deadline for Submission of Interim Status Report filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/9/21. (ntl)
Dec 9, 2021	411	Notice of Appearance (3) Docket Text: NOTICE of Appearance by Samantha G. Wilson on behalf of Sandoz Inc. (Wilson, Samantha)
Dec 9, 2021	412	Notice of Appearance (3) Docket Text: NOTICE of Appearance by Samantha G. Wilson on behalf of Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd. (Wilson, Samantha)
Dec 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [404] Stipulated Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/7/21. (ntl)
Dec 8, 2021	410	Letter (3) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Jointly Submitted Interim Status Report. (Balick, Steven)
Dec 7, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (394 in 1:19-cv-01938-LPS, 11 in 1:20-cv-01599-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zenara) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/6/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01599-LPS (ntl)
Dec 7, 2021	407	Stipulation (6) Docket Text: STIPULATION Seeking to Extend the Deadline for Submission of Interim Status Report, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Dec 6, 2021	406	Notice (Other) (2) Docket Text: NOTICE of Withdrawal of Kenneth L. Dorsney, Cortlan S. Hitch and Morris James LLP for Aurobindo by Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc. (Dorsney, Kenneth)
Dec 3, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [400] STIPULATION TO EXTEND TIME of deadline for fact discovery, with respect to Alembic only to December 3, 2021 filed by Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 12/2/21. (ntl)
Dec 3, 2021	404	Stipulation (6) Docket Text: STIPULATION Seeking to Extend the Deadline for Submission of Interim Status Report, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Dec 3, 2021	405	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Responses and Objections to Plaintiff's Second Set of Common Interrogatories to Defendants (Nos. 12-13); and Defendants Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd..(Palapura, Bindu)
Dec 1, 2021	401	Letter (30) Docket Text: Letter to The Honorable Leonard P. Stark from Kenneth L. Dorsney regarding Defendants' Joint Request for Leave to File a Joint Motion for Summary Judgment of Noninfringement of the '419 Patent. (Dorsney, Kenneth)
Dec 1, 2021	402	Main Document (7) Docket Text: Letter to The Honorable Leonard P. Stark from Thomas J. Francella, Jr. regarding the Apotex Defendants Seeking Leave to File a Motion for Summary Judgment of Non-Infringement of the '419 Patent. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5)(Francella, Thomas)
Dec 1, 2021	402	Exhibit 1 (16)
Dec 1, 2021	402	Exhibit 2 (1)
Dec 1, 2021	402	Exhibit 3 (40)
Dec 1, 2021	402	Exhibit 4 (10)
Dec 1, 2021	402	Exhibit 5 (15)
Nov 30, 2021	398	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Alkem Laboratories Supplemental Answers and Objections to Plaintiffs' Common Interrogatories Nos. 3-7, 9-10 and 12-13 [Highly Confidential] and First Supplemental Answers and Objections to Plaintiffs' Interrogatory Nos. 1 and 3-7 [Highly Confidential] filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Nov 30, 2021	399	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Supplemental Responses to Defendants' Common Interrogatories (Nos. 1-3, 5-9 and 12-13) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Nov 30, 2021	400	Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME of deadline for fact discovery, with respect to Alembic only to December 3, 2021 - filed by Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd.. (Palapura, Bindu)
Nov 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [392] STIPULATED ORDER Seeking to Extend Certain Case Deadlines filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/29/21. (ntl)
Nov 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01287-LPS, 390 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (Accord) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/29/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01287-LPS (ntl)
Nov 29, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (391 in 1:19-cv-01938-LPS, 15 in 1:20-cv-01428-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (MSN) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/29/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01428-LPS (ntl)
Nov 26, 2021	395	Notice of Appearance (2) Docket Text: NOTICE of Appearance by Richard Charles Weinblatt on behalf of Optimus Pharma Pvt. Ltd. (Weinblatt, Richard)
Nov 26, 2021	396	Notice of Appearance (2) Docket Text: NOTICE of Appearance by Richard Charles Weinblatt on behalf of Ajanta Pharma Ltd. (Weinblatt, Richard)
Nov 26, 2021	397	Notice of Appearance (2) Docket Text: NOTICE of Appearance by Richard Charles Weinblatt on behalf of Prinston Pharmaceutical Inc. (Weinblatt, Richard)
Nov 24, 2021	393	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Melric Mathias on November 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Nov 24, 2021	394	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Zenara), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 23, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [389] STIPULATION and Order Regarding Infringement of Certain Asserted Patents and Claims (Hetero) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/23/21. (ntl)
Nov 22, 2021	390	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (Accord), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 22, 2021	391	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation (MSN), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 22, 2021	392	Stipulation (6) Docket Text: STIPULATION Seeking to Extend Certain Case Deadlines, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01531-LPS, 387 in 1:19-cv-01938-LPS) STIPULATION and Order Regarding Partial Dismissal Without Prejudice and Consolidation. Signed by Judge Leonard P. Stark on 11/19/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01531-LPS (ntl)
Nov 19, 2021	389	Stipulation (3) Docket Text: STIPULATION Regarding Infringement of Certain Asserted Patents and Claims (Hetero), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 18, 2021	388	Notice of Appearance (2) Docket Text: NOTICE of Appearance by R. Touhey Myer on behalf of Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. (Myer, R.)
Nov 17, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [385] STIPULATION Seeking to Extend Deadlines for Close of Fact Discovery and Submission of Joint Status Report filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/17/21. (ntl)
Nov 17, 2021	387	Stipulation (4) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Hetero), by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 16, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Leah Brackensick for Cadila Healthcare Ltd. and Zydus Pharmaceuticals (USA) Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Nov 15, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [386] MOTION for Pro Hac Vice Appearance of Attorney Leah Brackensick filed by Zydus Pharmaceuticals (USA) Inc., Cadila Healthcare Ltd. Signed by Judge Leonard P. Stark on 11/15/21. (ntl)
Nov 15, 2021	386	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Leah Brackensick - filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc.. (Kraman, Pilar)
Nov 12, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [383] MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Guerra filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/12/21. (ntl)
Nov 12, 2021	385	Stipulation (6) Docket Text: STIPULATION Seeking to Extend Deadlines for Close of Fact Discovery and Submission of Joint Status Report, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 11, 2021	384	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc., and Signa S.A. de C.V.'s Second Supplemental Responses to Plaintiffs' Common Interrogatories to Defendants (Nos. 3-5, 7, 9 and 11-13), and Third Supplemental Response to Plaintiffs' Common Interrogatories to Defendants (No. 10) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Nov 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [382] STIPULATION Seeking to Extend the Deadline by Which Plaintiffs Must Seek Relief With Respect to Defendants' Disclosure of Dr. Richard Mailman Under the Protective Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/10/21. (ntl)
Nov 10, 2021	383	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kenneth S. Guerra - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 9, 2021	382	Stipulation (7) Docket Text: STIPULATION Seeking to Extend the Deadline by Which Plaintiffs Must Seek Relief With Respect to Defendants' Disclosure of Dr. Richard Mailman Under the Protective Order, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 1, 2021	381	Notice of Service (2) Docket Text: NOTICE OF SERVICE of SUPPLEMENTAL OBJECTIONS AND RESPONSE TO INTERROGATORY NO. 9 OF PLAINTIFFS FIRST SET OF INTERROGATORIES filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Hitch, Cortlan)
Oct 28, 2021	380	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendant Optimus Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 26, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (10 in 1:20-cv-01581-LPS, 377 in 1:19-cv-01938-LPS) STIPULATION and Order Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Aurobindo) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/26/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01581-LPS (ntl)
Oct 25, 2021	378	Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Dominick T. Gattuso regarding requesting the scheduling of a discovery teleconference on an expedited basis. (Gattuso, Dominick)
Oct 25, 2021	379	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Dominick T. Gattuso, Esquire regarding Alkem's letter (DI 378) - re [378] Letter. (Gattuso, Dominick)
Oct 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [375] STIPULATION Seeking to Extend the Close of Fact Discovery and Filing of Status Report filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S -- Fact Discovery completed by 11/12/2021. Status Report due by 11/19/2021. Signed by Judge Leonard P. Stark on 10/20/21. (ntl)
Oct 20, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [362] Stipulation of Dismissal filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S -- Party Unichem Laboratories Ltd. terminated. Attorney Renee Mosley Delcollo; Kelly E. Farnan; Andrew O. Larsen; Christopher J. Sorenson; Karen L. Beckman and B. Jefferson Boggs, Jr terminated. Signed by Judge Leonard P. Stark on 10/20/21. (ntl)
Oct 20, 2021	377	Stipulation (4) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Aurobindo), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [376] MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc. Signed by Judge Leonard P. Stark on 10/19/21. (ntl)
Oct 18, 2021	376	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Michael P. Hogan - filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc.. (Dorsney, Kenneth)
Oct 15, 2021	366	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anja Rupp on November 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	367	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Achint Jain on November 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	368	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Navin Vaya on October 22, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	369	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Cristina de Lima on October 21, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	370	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Second Supplemental Invalidity Contentions filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Oct 15, 2021	371	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Blessy Johns on November 4, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	372	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rohit Ghan on November 5, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	373	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pasula Basavaiah Chowdary on November 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	374	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Prashant Mandaogade on November 8, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 15, 2021	375	Stipulation (6) Docket Text: STIPULATION Seeking to Extend the Close of Fact Discovery and Filing of Status Report, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [354] MOTION for Pro Hac Vice Appearance of Attorney Kayvon M. Ghayoumi filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/14/21. (ntl)
Oct 14, 2021	363	Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Mary Hobart on November 10, 2021 filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Oct 14, 2021	364	Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Tine Stensbol on November 9, 2021 filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Oct 14, 2021	365	Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of John Arena on October 29, 2021 filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Oct 13, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 1:21-cv-00580-LPS, 347 in 1:19-cv-01938-LPS) STIPULATION and Order Regarding Dismissal Without Prejudice and Consolidation. Signed by Judge Leonard P. Stark on 10/13/21. Associated Cases: 1:19-cv-01938-LPS, 1:21-cv-00580-LPS (ntl)
Oct 13, 2021	362	Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Without Prejudice by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 12, 2021	352	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Narenda Racharla on October 14, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 12, 2021	353	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Manas Ranjan Pradhan on October 13, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Oct 12, 2021	354	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kayvon M. Ghayoumi - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 12, 2021	355	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex PharmaChem Inc., and Signa S.A. de C.V.'s First Supplemental Response to Plaintiffs' Common Interrogatories to Defendants (No. 11) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Oct 12, 2021	356	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Aurobindo Pharma Ltd. and Aurobindo Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 12, 2021	357	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendant Prinston Pharmaceutical Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 12, 2021	358	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc. and MSN Life Sciences Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 12, 2021	359	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Macleods Pharmaceuticals Ltd. and Macleods Pharma USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 12, 2021	360	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendant Accord Healthcare Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 12, 2021	361	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Supplemental Infringement Contentions (Defendant Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 11, 2021	349	Notice to Take Deposition (7) Docket Text: NOTICE to Take Deposition of Masafumi Toda on November 4, 2021 filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Oct 11, 2021	350	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc., and Signa S.A. de C.V.'s Objections and Supplemental Responses to Plaintiffs' Notice of Deposition of Defendants Apotex Inc., et al. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Oct 11, 2021	351	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendant Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 7, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [348] MOTION for Pro Hac Vice Appearance of Attorney Paul W. Browning filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 10/7/21. (ntl)
Oct 6, 2021	348	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Paul W. Browning - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 5, 2021	347	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Sandoz Inc.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 4, 2021	346	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sandoz Inc.'s First Supplemental Objections and Responses to Plaintiffs' Interrogatory No. 9 filed by Sandoz Inc..(Vrana, Robert)
Oct 1, 2021	345	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Second Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1 and 3) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 30, 2021	344	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s (1) First Supplemental Responses to Plaintiffs' Common Interrogatories to Defendants (Nos. 2-5, 7, 12 and 13) and Second Supplemental Response to Plaintiffs' Common Interrogatories to Defendants (No. 10); and (2) Supplemental Initial Disclosures Pursuant to Rule 26(a)(1) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Sep 20, 2021	343	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Otsuka Pharmaceutical's Notice of Depositions of Defendants Pursuant to Fed. R. Civ. P. 30(B)(6) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth)
Sep 17, 2021	342	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Unichem Laboratories, Ltd.'s Responses to Plaintiffs' First Set of Interrogatories to Unichem Laboratories, Ltd., (2) Defendant Unichem Laboratories, Ltd.'s Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-3) and Authentication (Nos. 1-2), (3) Defendant Unichem Laboratories, Ltd.'s Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19), and (4) Defendant Unichem Laboratories, Ltd.'s Answers to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) filed by Unichem Laboratories Ltd..(Farnan, Kelly)
Sep 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [341] MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner of Rakoczy Molino Mazzochi Siwik LLP filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 9/14/21. (ntl)
Sep 14, 2021	341	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin E. Warner of Rakoczy Molino Mazzochi Siwik LLP - filed by Alkem Laboratories Ltd.. (Gattuso, Dominick)
Sep 13, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [337] STIPULATION Regarding Extension of Fact Discovery, Extension of Joint Status Report, and Issues Relating to Depositions and Discovery -- Fact Discovery completed by 10/15/2021. Status Report due by 10/22/2021. Signed by Judge Leonard P. Stark on 9/13/21. (ntl)
Sep 10, 2021	336	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); 2) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs' First Set of Interrogatories to Zydus Pharmaceuticals (USA) Inc., et al. (Nos. 1-6); 3) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-2); and 4) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar)
Sep 10, 2021	337	Stipulation (7) Docket Text: STIPULATION Regarding Extension of Fact Discovery, Extension of Joint Status Report, and Issues Relating to Depositions and Discovery, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Sep 10, 2021	338	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Zydus' First Set of Interrogatories to Plaintiffs (Nos. 1-5) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 10, 2021	339	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Teva's Second Set of Interrogatories to Plaintiffs (Nos. 7-10) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 10, 2021	340	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Teva Pharmaceuticals USA, Inc.'s Supplemental Responses and Objections to Plaintiffs Otsuka Pharmaceutical Co. Ltd., and H. Lundbeck A/S's First Set of Interrogatories (Nos. 1-11) (2) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 12, 13) (3) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-3) and Authentication (Nos. 1-2) (4) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition of Teva Pharmaceuticals USA Inc. (Nos. 1-35) Pursuant to Fed. R. Civ. P. 30(b)(6) (5) Defendant Teva Pharmaceuticals USA, Inc.'s Second Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and the Delaware Default Standard for Discovery (6) Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Interrogatories to Teva Pharmaceuticals USA, Inc. (No. 1) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Sep 9, 2021	334	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Objections and Responses to Plaintiffs' First Set of Common Requests for Admissions (Nos. 1-19) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Sep 9, 2021	335	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Teva's First Set of Requests for Admission to Plaintiffs (Nos. 1-15) and Plaintiffs' Objections and Responses to Teva's First Set of Requests for the Production of Documents and Things (Nos. 1-3) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (10 in 1:21-cv-00316-LPS, 310 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice and Regarding Consolidation filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 9/8/21. Associated Cases: 1:19-cv-01938-LPS, 1:21-cv-00316-LPS (ntl)
Sep 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [330] Stipulated Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 9/8/21. (ntl)
Sep 8, 2021	332	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Joint Supplemental Invalidity Contentions (2) Appendix Nos. 1-6 to Defendants' Joint Supplemental Invalidity Contentions filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Sep 8, 2021	333	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responses And Objections To Plaintiffs' First Set Of Interrogatories To Alembic Pharmaceuticals Ltd., et al. (Nos. 1-4) [Confidential]; and Alembic Pharmaceuticals Ltd. And Alembic Pharmaceuticals, Inc.'s Responses And Objections To Plaintiff's First Set Of Requests For Admission (Nos. 1-7) And Authentication (Nos. 1-2) [Confidential] filed by Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd..(Palapura, Bindu)
Sep 7, 2021	331	Notice Requesting Removal of Co-Counsel (1) Docket Text: NOTICE requesting Clerk to remove Amy D. Brody as co-counsel. Reason for request: Left Firm. (Gattuso, Dominick)
Sep 3, 2021	318	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Amneal's Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2); 2) Amneal's Responses to Plaintiffs' First Set of Interrogatories to Amneal (Nos. 1-4); 3) Amneal's Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); and 4) Amneal's Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd..(Vrana, Robert)
Sep 3, 2021	319	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Sandoz Inc.'s Objections and Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); 2) Sandoz Inc.'s Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12- 13); 3) Sandoz Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-6) and Authentication (Nos. 1-2); and 4) Sandoz Inc.'s Responses to Plaintiffs' First Set of Interrogatories to Sandoz Inc. (Nos. 1-2) filed by Sandoz Inc..(Vrana, Robert)
Sep 3, 2021	320	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses and objections to second set of common interrogatories (Nos. 12-13) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth)
Sep 3, 2021	321	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Macleods' Supplemental Rule 26(a)(1) Initial Disclosures; and (2) Macleods' Supplemental Response to Plaintiffs' Common Interrogatory No. 9 filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Sep 3, 2021	322	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Alkem Laboratories Ltd.'s Answers and Objections to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) [HIGHLY CONFIDENTIAL]; and, (ii) Defendant Alkem Laboratories Ltd.'s Supplemental Answer and Objections to Plaintiffs' Common Interrogatory No. 9 [HIGHLY CONFIDENTIAL] filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Sep 3, 2021	323	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Hetero's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) filed by Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd..(Dorsney, Kenneth)
Sep 3, 2021	324	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1)Responses to second set of common interrogatories (Nos. 12-13); (2) Responses to first set of interrogatories (Nos. 1-5) and (3) Responses to first set of requests for admission (Nos. 1-6) and first set of requests for authentication (Nos. 1-3) filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Sep 3, 2021	325	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 12-13) and Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s [HIGHLY CONFIDENTIAL] Supplemental Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 3-7, 9, 11) filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Sep 3, 2021	326	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Amneal's First Set of Interrogatories (Nos. 1-6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 3, 2021	327	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Sandoz's First Set of Interrogatories (Nos. 1-2) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 3, 2021	328	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Accord's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) and (ii) MSN's Objections and Responses to Plaintiffs' Second Set of Common Interrogatories (Nos. 12-13) filed by Accord Healthcare Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Seaman, John)
Sep 3, 2021	329	Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s (1) Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) to Apotex Inc., et al.; (2) First Supplemental Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 8-10); (3) Objections and Responses to Plaintiffs' First Set of Interrogatories to Apotex Inc., et al. (Nos. 1-5); and (4) Objections and Responses to Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 12-13) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Sep 3, 2021	330	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Close of Fact Discovery, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Sep 2, 2021	302	Notice of Service (2) Docket Text: NOTICE OF SERVICE of responses and objections to first set of common requests for admission (Nos. 1-19) filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Sep 2, 2021	303	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1)RESPONSES TO FIRST SET OF REQUESTS FOR ADMISSION (NOS. 1-5) AND AUTHENTICATION (NOS. 1-3); (2)RESPONSES TO FIRST SET OF COMMON REQUESTS FOR ADMISSION (NOS. 1-19); (3)RESPONSES TO FIRST SET OF INTERROGATORIES (NOS. 1-2); and (4) RESPONSES SECOND SET OF COMMON INTERROGATORIES (NOS. 12-13) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Sep 2, 2021	304	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Hetero's Objections and Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); (2) Hetero's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-3) and; (3) Hetero's Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-6) filed by Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd..(Dorsney, Kenneth)
Sep 2, 2021	305	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) [HIGHLY CONFIDENTIAL] Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); (2) [HIGHLY CONFIDENTIAL] Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-5) and Authentication (Nos. 1-3) to Lupin Limited and Lupin Pharmaceuticals, Inc.; and (3) [HIGHLY CONFIDENTIAL] Responses to Plaintiffs' First Set of Interrogatories to Lupin Limited and Lupin Pharmaceuticals, Inc. (Nos. 1-2) filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Sep 2, 2021	306	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Alkem Laboratories Ltd.'s Answers and Objections to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19) [HIGHLY CONFIDENTIAL]; (ii) Defendant Alkem Laboratories Ltd.'s Answers and Objections to Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-2) [HIGHLY CONFIDENTIAL]; and, (iii) Defendant Alkem Laboratories Ltd.'s Answers and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-7) [HIGHLY CONFIDENTIAL] filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Sep 2, 2021	307	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19); (2) Aurobindo's Responses and Objections to Plaintiffs' First Set of Interrogatories (Nos. 1-4) and; (3) Aurobindo's Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-3) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth)
Sep 2, 2021	308	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Hetero's First Set of Individual Requests for Admissions (Nos. 1-7) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 2, 2021	309	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Zenara's and Biophore's First Set of Individual Requests for Admissions (Nos. 1-14) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 2, 2021	310	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Sep 2, 2021	311	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Accord's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2); (ii) MSN's Objections and Responses to Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2); (iii) Accord's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-5); (iv) MSN's Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-4); (v) Accord's Objections and Responses to Plaintiffs' First Common Set of Requests for Admission (Nos. 1-19); and (vi) MSN's Objections and Responses to Plaintiffs' First Common Set of Requests for Admission (Nos. 1-19) filed by Accord Healthcare Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Seaman, John)
Sep 2, 2021	312	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Lupin's First Set of Individual Interrogatories (Nos. 1-4) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 2, 2021	313	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Alkem's First Set of Individual Interrogatories (Nos. 1-4) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 2, 2021	314	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Objections and Responses to Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Sep 2, 2021	315	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant Ajanta Pharma Ltd.s Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-8) and Authentication (Nos. 1-2)(Ajanta Pharma Ltd.), (2) Defendant Ajanta Pharma Ltd.s Objections and Responses to Plaintiffs First Set of Common Requests for Admission (Nos. 1-19), (3) Defendant Ajanta Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Interrogatories to Ajanta Pharma Ltd. (Nos. 1-6), and (4) Defendant Ajanta Pharma Ltd.s Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 12-13) filed by Ajanta Pharma Ltd..(Stamoulis, Stamatios)
Sep 2, 2021	316	Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Requests for Admission (Nos. 1-5) and Authentication (Nos. 1-2)(Optimus Pharma Pvt. Ltd.), (2) Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Common Requests for Admission (Nos. 1-19), (3) Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Interrogatories to Optimus Pharma Pvt. Ltd. (Nos. 1-2), and (4) Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 12-13) filed by Optimus Pharma Pvt. Ltd..(Stamoulis, Stamatios)
Sep 2, 2021	317	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Prinstons Objections and Responses to Plaintiffs First Set of Interrogatories to Prinston (Nos. 1-5), (2) Prinstons Objections and Responses to Plaintiffs Second Set of Common Interrogatories to Defendants (Nos. 12-13), (3) Prinstons Response and Objections to Defendants First Set of Common Requests for Admission (1-19), and (4) Prinstons Response and Objections to Defendants First Set of Requests for Admission to Prinston (1-9) and Authenication (1-2) filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios)
Sep 1, 2021	300	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Accord's First Set of Individual Interrogatories (Nos. 1-6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Sep 1, 2021	301	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to MSN's First Set of Individual Interrogatories (Nos. 1-10) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 31, 2021	299	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Accord's Objections and Responses to Plaintiffs' Notice of Deposition and (ii) MSN's Objections and Responses to Plaintiffs' Notice of Deposition filed by Accord Healthcare Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Seaman, John)
Aug 30, 2021	292	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Macleods' Objections to Plaintiffs' Notice of 30(b)(6) Deposition filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Aug 30, 2021	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' letters and related materials (see, e.g., D.I. 285, 287), IT IS HEREBY ORDERED that Defendants' request to compel Otsuka to comply with the Delaware Default Standard ("DDS") and produce all metadata fields outlined in para. 5(e) for all previous and future document productions -- to the extent such metadata exists and has not yet been produced -- is GRANTED. Because the parties have not entered into their own stipulated ESI order, the DDS applies (see DDS para. 1(a)) ("In the event that the parties are unable to agree on the parameters and/or timing of discovery, the following default standards shall apply until further order of the Court or the parties reach agreement."), making production of the metadata outlined in para. 5(e) of the DDS required "to the extent such metadata exists." Plaintiffs represent that no custodian metadata exists, but they do not argue that file path and author information metadata also do not exist. (See D.I. 287 at 2) In addition to being required by the DDS, the prejudice to Defendants (for example, in connection with their ability to use documents at depositions) from not having the metadata appears to outweigh any burden to Otsuka from producing the existing metadata. While both sides must comply with the DDS, the Court has before it only a ripe dispute pressed by Defendants; the Court will address any issue Otsuka raises if Otsuka chooses to do so. ORDERED by Judge Leonard P. Stark on 8/30/21. (ntl)
Aug 30, 2021	294	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Defendant Alkem Laboratories Ltd.'s Responses and Objections to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6); (ii) Defendant Alkem Laboratories Ltd.'s Supplemental Answers and Objections to Plaintiffs' Common Interrogatory Nos. 3, 6 and 7 [HIGHLY CONFIDENTIAL]; and (iii) Defendant Alkem Laboratories Ltd.'s Amended Answers and Objections to Plaintiffs' Common Interrogatory Nos. 2, 5 and 10 filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Aug 30, 2021	295	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Macleods' First Set of Interrogatories (Nos. 1-6) and Plaintiffs' Objections and Responses to Macleods' First Set of Document Requests (Nos. 1- 5) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 30, 2021	296	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Teva's First Set of Interrogatories to Plaintiffs (Nos. 1-6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 30, 2021	297	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for Admissions (Nos. 1-16) and Plaintiffs' Objections and Responses to Defendants' Third Set of Common Interrogatories (Nos. 9-14) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 30, 2021	298	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Lundbeck's Objections and Responses to Defendants' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) and Otsuka's Objections and Responses to Defendants' Notice of Deposition Pursuant to Federal Rule of Civil Procedure 30(b)(6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 27, 2021	290	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Objections and Responses to Plaintiffs' Notice of Deposition of Defendants Apotex Inc., et al. Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Aug 27, 2021	291	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amneal's Objections and Responses to Plaintiffs Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd..(Vrana, Robert)
Aug 26, 2021	289	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Sandoz Inc.'s Objections and Responses to Plaintiffs' Notice of Deposition of Defendant Sandoz Inc. Pursuant to Fed. R.Civ. P. 30(b)(6) filed by Sandoz Inc..(Vrana, Robert)
Aug 20, 2021	287	Main Document (4) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding Plaintiffs' Opposition to Defendants' August 18, 2021 Discovery Letter (D.I. 285). (Attachments: # (1) Exhibit A)(Balick, Steven)
Aug 20, 2021	287	Exhibit A (24)
Aug 20, 2021	288	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Ajanta Pharma Limiteds Objections and Responses to Plaintiffs Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Ajanta Pharma Ltd.) filed by Ajanta Pharma Ltd..(Stamoulis, Stamatios)
Aug 19, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Teresa M. Summers for Accord Healthcare Inc.,MSN Laboratories Pvt. Ltd., and MSN Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs)
Aug 19, 2021	286	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Optimus Pharma Pvt. Ltd.) filed by Optimus Pharma Pvt. Ltd..(Stamoulis, Stamatios)
Aug 18, 2021	285	Main Document (10) Docket Text: Letter to The Honorable Leonard P. Stark from Defendants regarding Discovery Dispute Concerning the Production of Plaintiffs' Metadata - re [283] Order,,,. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G)(Kraman, Pilar)
Aug 18, 2021	285	Exhibit A (6)
Aug 18, 2021	285	Exhibit B (17)
Aug 18, 2021	285	Exhibit C (3)
Aug 18, 2021	285	Exhibit D (7)
Aug 18, 2021	285	Exhibit E (2)
Aug 18, 2021	285	Exhibit F (2)
Aug 18, 2021	285	Exhibit G (2)
Aug 16, 2021	N/A	Order (0) Docket Text: ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter (D.I. 112), IT IS HEREBY ORDERED that not later than August 18, 2021, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than August 20, 2021, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Each party shall submit to the Court two (2) courtesy copies of its discovery letter and any attachments. After reviewing the letter submissions, the Court may schedule a teleconference. ORDERED by Judge Leonard P. Stark on 8/16/21. (ntl)
Aug 16, 2021	284	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Common Interrogatories (Nos. 6-8) and Plaintiffs' Objections and Supplemental Responses to Defendants' First Set of Common Interrogatories (Nos. 1-5) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 13, 2021	281	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Notice of Deposition Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Lupin Limited, Lupin Pharmaceuticals Inc..(Bilson, David)
Aug 13, 2021	282	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals Company GmbH and Raks Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 11, 2021	280	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s First Amended Initial Disclosures Pursuant to Rule 26(a)(1) filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Aug 9, 2021	276	Notice of Service (2) Docket Text: NOTICE OF SERVICE of objections to 30(b)(6) notice of deposition filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth)
Aug 9, 2021	277	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Hetero's First Set of Individual Interrogatories (No. 1) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Aug 9, 2021	278	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Zenara's and Biophore's First Set of Individual Interrogatories (No. 1) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Aug 9, 2021	279	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Prinstons Responses and Objections to Defendants 30(b)(6) Deposition Notice filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios)
Aug 5, 2021	272	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Biophore's objections and responses to Plaintiffs' 30(b)(6) deposition notice; and (2); Hetero's objections and responses to Plaintiffs' 30(b)(6) deposition notice filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd..(Hitch, Cortlan)
Aug 5, 2021	273	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's First Set of Interrogatories to Plaintiffs (Nos. 1-5) filed by Zydus Pharmaceuticals (USA) Inc..(Kraman, Pilar)
Aug 5, 2021	274	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Amneal's First Set of Interrogatories (Nos. 1- 6) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd..(Vrana, Robert)
Aug 5, 2021	275	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Sandoz's First Set of Interrogatories (Nos. 1- 2) filed by Sandoz Inc..(Vrana, Robert)
Aug 4, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (252 in 1:19-cv-01938-LPS, 14 in 1:20-cv-01296-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice and Consolidation filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 8/4/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01296-LPS (ntl)
Aug 4, 2021	262	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Zenara Pharma Pvt. Ltd., et al. (Nos. 1-5) and Plaintiffs' First Set of Requests for Admission (Nos. 1-6) and Authentication (Nos. 1-3) (Zenara Pharma Private Ltd., et. al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	263	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Unichem Laboratories Ltd. and Plaintiffs' First Set of Requests for Admission (Nos. 1-3) and Authentication (Nos. 1-2) (Unichem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	264	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Prinston Pharmaceutical Inc. (Nos. 1-5) and Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-2) (Prinston Pharmaceutical Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	265	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Optimus Pharma Pvt. Ltd. (Nos. 1-2) and Plaintiffs' First Set of Requests for Admission (Nos. 1-5) and Authentication (Nos. 1-2) (Optimus Pharma Pvt. Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	266	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Apotex Inc., et al. (Nos. 1-5) and Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) (Apotex Inc., et. al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	267	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Amneal Pharmaceuticals LLC, et al. (Nos. 1-4) and Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) (Amneal Pharmaceuticals LLC, et. al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	268	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-8) and Authentication (Nos. 1-2) (Ajanta Pharma Ltd.) and Plaintiffs' First Set of Interrogatories to Ajanta Pharma Ltd. (Nos. 1-6) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	269	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-3) and Authentication (Nos. 1-2) (Teva Pharmaceuticals USA, Inc.) and Plaintiffs' First Set of Interrogatories to Teva Pharmaceuticals USA, Inc. (No. 1) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	270	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Common Interrogatories to Defendants (Nos. 12-13) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 4, 2021	271	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Second Set of Interrogatories (Nos. 7-10) to Plaintiffs filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Aug 3, 2021	247	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Requests for Admission (Nos. 1-19) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	248	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Hetero Labs Ltd., et al. (Nos. 1-6) and Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-3) (Hetero Labs Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	249	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Hetero's First Set of Individual Requests for Admission (Nos. 1-7) and; (2) Biophore's First Set of Individual Requests for Admission (Nos. 1-14) filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Zenara Pharma Private Ltd..(Hitch, Cortlan)
Aug 3, 2021	250	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Lupin Limited, et al. (Nos. 1-2) and Plaintiffs' First Set of Requests for Admission (Nos. 1-5) and Authentication (Nos. 1-3) (Lupin Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	251	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-3) (Aurobindo Pharma Ltd., et al.) and Plaintiffs' First Set of Interrogatories to Aurobindo Pharma Ltd., et al. (Nos. 1-4) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	252	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims Without Prejudice, and Regarding Consolidation, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Aug 3, 2021	253	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) (Accord Healthcare Inc.) and Plaintiffs' First Set of Interrogatories to Accord Healthcare Inc. (Nos. 1-5) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	254	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s First Set of Individual Interrogatories (Nos. 1-4) filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Aug 3, 2021	255	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Alkem Laboratories Ltd. (Nos. 1-7) and Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-2) (Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	256	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) (Alembic Pharmaceuticals Ltd., et al.) and Plaintiffs' First Set of Interrogatories to Alembic Pharmaceuticals Ltd., et al. (Nos. 1-4) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	257	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Macleods Pharmaceuticals Ltd., et al. (Nos. 1-2) and Plaintiffs' First Set of Requests for Admission (Nos. 1-5) and Authentication (Nos. 1-3) (Macleods Pharmaceuticals Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	258	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Sandoz Inc. (Nos. 1-2) and Plaintiffs' First Set of Requests for Admission (Nos. 1-6) and Authentication (Nos. 1-2) (Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	259	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories to Zydus Pharmaceuticals (USA) Inc., et al. (Nos. 1-6) and Plaintiffs' First Set of Requests for Admission (Nos. 1-9) and Authentication (Nos. 1-2) (Zydus Pharmaceuticals (USA) Inc., et. al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	260	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Admission (Nos. 1-7) and Authentication (Nos. 1-2) (MSN Laboratories Pvt. Ltd., et. al.) and Plaintiffs' First Set of Interrogatories to MSN Laboratories Pvt. Ltd., et al. (Nos. 1-4) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 3, 2021	261	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Teva's First Set of Requests for the Production of Documents and Things (Nos. 1-3) 2. Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Requests for Admission to Plaintiffs (Nos. 1-15) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Aug 2, 2021	227	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendants' First Set of Requests for Admission to Plaintiffs (Nos. 1-16) 2. Defendants' Third Set of Common Interrogatories (Nos. 9-14) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Aug 2, 2021	228	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Accord's First Set of Interrogatories (Nos. 1-6) and (ii) MSN's First Set of Interrogatories (Nos. 1-10) filed by Accord Healthcare Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc..(Seaman, John)
Aug 2, 2021	229	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Accord Healthcare Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	230	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Ajanta Pharma Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	231	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Alembic Pharmaceuticals Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	232	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Amneal Pharmaceuticals LLC, et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	233	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Alkem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	234	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Apotex Inc., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	235	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Aurobindo Pharma Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	236	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Hetero Labs Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	237	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Lupin Limited, et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	238	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Macleods Pharmaceuticals Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	239	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (MSN Laboratories Pvt. Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	240	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Optimus Pharma Pvt. Ltd.) filed by Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	241	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Prinston Pharmaceutical Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	242	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	243	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Teva Pharmaceuticals USA, Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	244	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendant Pursuant to Fed. R. Civ. P. 30(b)(6) (Unichem Laboratories Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	245	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Zenara Pharma Private Ltd., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Aug 2, 2021	246	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Notice of Deposition of Defendants Pursuant to Fed. R. Civ. P. 30(b)(6) (Zydus Pharmaceuticals (USA) Inc., et al.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	173	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Macleods' First Set of Individual Interrogatories to Plaintiffs (Nos. 1-6); and (2) Macleods' First Set of Individual Requests for Production to Plaintiffs (Nos. 1-5) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Jul 30, 2021	174	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Shailesh Gohad (Macleods Pharmaceuticals Ltd., et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	175	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pratap Reddy Padi (Macleods Pharmaceuticals Ltd., et al.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	176	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Mayur Khunt (Macleods Pharmaceuticals Ltd., et al.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	177	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Hiteshkumar Maheshwari (Macleods Pharmaceuticals Ltd., et al.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	178	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of P. Madhukumar (MSN Laboratories Pvt. Ltd., et al.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	179	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of G. Kiran (MSN Laboratories Pvt. Ltd., et al.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	180	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sarat Chandra Peddu (MSN Laboratories Pvt. Ltd., et al.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	181	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of PVSR. Subrahmanyam (MSN Laboratories Pvt. Ltd., et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	182	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ravikumar Nitiyanandam (MSN Laboratories Pvt. Ltd., et al.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	183	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of P. Prashanth Reddy (Optimus Pharma Pvt. Ltd.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	184	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of P. Kranthi Kumar (Optimus Pharma Pvt. Ltd.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	185	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ramachandra Rao J. (Optimus Pharma Pvt. Ltd.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	186	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Priyaranjan Pattanaik (Optimus Pharma Pvt. Ltd.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	187	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of P. Ramakrishna Raju (Optimus Pharma Pvt. Ltd.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	188	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Y. Raveendra Reddy (Optimus Pharma Pvt. Ltd.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	189	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of V. Govind Reddy (Optimus Pharma Pvt. Ltd.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	190	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of B. Satyanarayana Rao (Optimus Pharma Pvt. Ltd.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	191	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of N. Kiran Kumar (Optimus Pharma Pvt. Ltd.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	192	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of K. Rajashekar (Optimus Pharma Pvt. Ltd.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	193	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Xiangxin (Cindy) Meng (Prinston Pharmaceutical Inc.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	194	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Yiming Tang (Prinston Pharmaceutical Inc.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	195	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pei Zhang (Prinston Pharmaceutical Inc.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	196	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Lijie Wang, Ph.D. (Prinston Pharmaceutical Inc.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	197	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Marianne Kozhan-Gorodetska (Sandoz Inc.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	198	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Renata Degady (Sandoz Inc.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	199	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Melissa Henry (Sandoz Inc.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	200	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Diana Dai (Sandoz Inc.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	201	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Amita Gavaskar (Sandoz Inc.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	202	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Hemant Kumar Mamania (Teva Pharmaceuticals USA, Inc.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	203	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Shreyas Gupte (Teva Pharmaceuticals USA, Inc.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	204	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Elena Tsibulsky (Teva Pharmaceuticals USA, Inc.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	205	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Eric Klingaman (Teva Pharmaceuticals USA, Inc.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	206	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Elisabeth Gray (Teva Pharmaceuticals USA, Inc.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	207	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Saji Mathew (Teva Pharmaceuticals USA, Inc.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	208	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of John Derstine (Teva Pharmaceuticals USA, Inc.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	209	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Raveendra Nagella (Teva Pharmaceuticals USA, Inc.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	210	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Rushi D. Advaryu (Unichem Laboratories Ltd.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	211	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Mangesh Sahane (Unichem Laboratories Ltd.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	212	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Mahesh Jagdale (Unichem Laboratories Ltd.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	213	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sunil Jog (Unichem Laboratories Ltd.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	214	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Scott Delaney (Unichem Laboratories Ltd.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	215	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Vishal Kulkarni (Unichem Laboratories Ltd.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	216	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Dnyaneshawar Gawas (Unichem Laboratories Ltd.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	217	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Vivek Mishra (Unichem Laboratories Ltd.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	218	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vancha Sathish Reddy (Zenara Pharma Private Ltd., et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	219	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Praveen Kumar (Zenara Pharma Private Ltd., et al.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	220	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Venkatesh Murugan (Zenara Pharma Private Ltd., et al.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	221	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Bhaskar Reddy (Zenara Pharma Private Ltd., et al.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	222	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pradeep Kumar V. (Zenara Pharma Private Ltd., et al.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	223	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vimal Kaneria (Zydus Pharmaceutical (USA) Inc., et al.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	224	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Elizabeth Purcell (Zydus Pharmaceutical (USA) Inc., et al.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	225	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Sanjay Desai (Zydus Pharmaceutical (USA) Inc., et al.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 30, 2021	226	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of G. Srinivas (Zydus Pharmaceutical (USA) Inc., et al.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	128	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of H. LUNDBECK A/S filed by Ajanta Pharma Ltd..(Stamoulis, Stamatios)
Jul 29, 2021	129	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of OTSUKA PHARMACEUTICAL CO., LTD. filed by Ajanta Pharma Ltd..(Stamoulis, Stamatios)
Jul 29, 2021	130	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s First Set of Interrogatories (Nos. 1-6) to Plaintiffs filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Jul 29, 2021	131	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sabita Nair (Accord Healthcare Inc.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	132	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Alpesh Pathak (Accord Healthcare Inc.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	133	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ashutosh Jamloki on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	134	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Manohar Lalge on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	135	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sunil Nair (Ajanta Pharma Ltd.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	136	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Ramesh Jhawar (Ajanta Pharma Ltd.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	137	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Surjya Panda (Ajanta Pharma Ltd.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	138	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Soma De (Ajanta Pharma Ltd.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	139	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Adwait Deo (Ajanta Pharma Ltd.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	140	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Shailesh Singh (Ajanta Pharma Ltd.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	141	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jacqueline Chalissery (Ajanta Pharma Ltd.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	142	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vivek Avasatthi (Alembic Pharmaceuticals Ltd., et al.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	143	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Virendra Srivastava (Alembic Pharmaceuticals Ltd., et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	144	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vittal T (Alembic Pharmaceuticals Ltd., et al.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	145	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Vipul Gajjar (Alembic Pharmaceuticals Ltd., et al.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	146	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Urvishkumar Shah (Alembic Pharmaceuticals Ltd., et al.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	147	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pratik Kumar (Alembic Pharmaceuticals Ltd., et al.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	148	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kapil Gupta (Amneal Pharmaceuticals LLC, et al.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	149	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Candis Edwards (Amneal Pharmaceuticals LLC, et al.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	150	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jameeluddin Fakhruddin (Alkem Laboratories Ltd.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	151	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ujwal Chhabra (Alkem Laboratories Ltd.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	152	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Prashant M. Mandaogade (Alkem Laboratories Ltd.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	153	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Bhushan Aher (Alkem Laboratories Ltd.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	154	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ramesh Raghavendra (Aurobindo Pharma Ltd., et al.) on August 26, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	155	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of M. Nagash (Aurobindo Pharma Ltd., et al.) on August 25, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	156	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Krishnamurthy Moturu (Aurobindo Pharma Ltd., et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	157	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of V. Naga Prasad (Aurobindo Pharma Ltd., et al.) on August 27, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	158	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of K. K. C. Dasarathi (Aurobindo Pharma Ltd., et al.) on August 24, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	159	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Prince Kumar Devadas (Aurobindo Pharma Ltd., et al.) on August 30, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	160	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Kiran Krishnan (Apotex Inc.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	161	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Bhupesh Singh (Apotex Inc.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	162	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Xiao-Ping (Irene) Wang (Apotex Inc.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	163	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Sandeep Patel (Apotex Inc.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	164	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gennady Ananchenko (Apotex Inc.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	165	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Leacroft Longmore (Apotex Inc.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	166	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Somaraju Indukuri (Hetero Labs Ltd., et al.) on September 2, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	167	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of K. Subhash Chander Reddy (Hetero Labs Ltd., et al.) on September 1, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	168	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Ganesh Madishetty (Hetero Labs Ltd., et al.) on August 31, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	169	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Makarand Avachat (Lupin Limited, et al.) on August 20, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	170	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jason Gensburger (Lupin Limited, et al.) on August 19, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	171	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pramod Dahibhate (Lupin Limited, et al.) on August 23, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 29, 2021	172	Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Girij Singh (Lupin Limited, et al.) on September 3, 2021 filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 27, 2021	126	Memorandum Opinion (12) Docket Text: MEMORANDUM OPINION re claim construction. Signed by Judge Leonard P. Stark on 7/27/21. (ntl)
Jul 27, 2021	127	Order (1) Docket Text: ORDER re [126] Memorandum Opinion regarding claim construction. Signed by Judge Leonard P. Stark on 7/27/21. (ntl)
Jul 23, 2021	113	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Haruka Takahashi on August 31, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	114	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Hideaki Kuroda on August 30, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	115	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Hiroshi Yamashita on August 23, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	116	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Jun Matsubara on August 27, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Apotex Inc., Apotex Pharmachem Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	117	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Kunio Oshima on August 26, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	118	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Nobuaki Ito on August 24, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	119	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Satoshi Shimizu on September 1, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	120	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Shin Miyamura on August 25, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	121	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Shinichi Taira on August 19, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	122	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Tatsuyoshi Tanaka on September 2, 2021 filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	123	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Yasuo Oshiro on August 20, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	124	Notice to Take Deposition (9) Docket Text: NOTICE to Take Deposition of Yoshiharu Inoue. on September 3, 2021 filed by Accord Healthcare Inc., Ajanta Pharma Ltd., Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd., Alkem Laboratories Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Cadila Healthcare Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Lupin Limited, Lupin Pharmaceuticals Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Optimus Pharma Pvt. Ltd., Prinston Pharmaceutical Inc., Raks Pharma Pvt. Ltd., Sandoz Inc., Signa S.A. de C.V., Teva Pharmaceuticals USA Inc., Unichem Laboratories Ltd., Zenara Pharma Private Ltd., Zydus Pharmaceuticals (USA) Inc..(Vrana, Robert)
Jul 23, 2021	125	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contention filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Jul 21, 2021	112	Letter (3) Docket Text: Letter to The Honorable Leonard P. Stark from Pilar G. Kraman regarding Request for the Scheduling of a Discovery Teleconference. (Kraman, Pilar)
Jul 16, 2021	111	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Second Set of Common Interrogatories (Nos. 6-8) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Jul 14, 2021	110	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Teva Pharmaceuticals USA, Inc.'s Supplemental Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and the Delaware Default Standard for Discovery filed by Teva Pharmaceuticals USA Inc..(Keller, Karen)
Jul 9, 2021	109	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Biophore and Hetero's First Set of Individual Interrogatories to Plaintiffs (No. 1) filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Zenara Pharma Private Ltd..(Hitch, Cortlan)
Jul 8, 2021	105	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Zenara Pharma Private Ltd. and Biophore India Pharmaceuticals Private Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 8, 2021	106	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA, Inc., Hetero Drugs Ltd. and Honour Lab Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 8, 2021	107	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendant Sandoz Inc.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 8, 2021	108	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions (Defendants Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Ltd.) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Jul 6, 2021	103	Notice (Other) (4) Docket Text: NOTICE of Change of Firm Affiliation by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd. (Vrana, Robert)
Jul 6, 2021	104	Notice (Other) (4) Docket Text: NOTICE of Change of Firm Affiliation by Sandoz Inc. (Vrana, Robert)
Jun 29, 2021	102	Transcript (72) Docket Text: Official Transcript of Zoom Claim Construction Hearing (Markman) held before Chief Judge Leonard P. Stark on June 28, 2021. Court Reporter Brian Gaffigan, email: gaffigan@verizon.net. Transcript may be viewed at the court public terminal or ordered/purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 7/20/2021. Redacted Transcript Deadline set for 7/30/2021. Release of Transcript Restriction set for 9/27/2021.(bpg)
Jun 28, 2021	N/A	Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Markman Hearing held (by video) on 6/28/2021. (Court Reporter B. Gaffigan.) (ntl)
Jun 25, 2021	100	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Elizabeth A. DeFelice on behalf of Alkem Laboratories Ltd. (DeFelice, Elizabeth)
Jun 25, 2021	N/A	Order (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the Markman hearing on June 28, 2021 at 9:00 a.m. is available to the public using the following dial-in for audio access: Dial by your location +1 346 248 7799 US (Houston); +1 312 626 6799 US (Chicago); +1 646 558 8656 US (New York); +1 301 715 8592 US (Washington DC); Meeting ID: 944 2676 9552 Password: 547788. Audio reproduction of the proceeding is strictly prohibited. ORDERED by Judge Leonard P. Stark on 6/25/21. (ntl)
Jun 23, 2021	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' letter concerning the claim construction hearing scheduled for June 28 at 9:00 a.m. (D.I. 98), IT IS HEREBY ORDERED that the hearing will be conducted by videoconference. Defendants shall submit access information for the Court, including access information for any interested member of the public, in advance of the hearing. IT IS FURTHER ORDERED that each party shall submit any slides or other materials to be referenced at the hearing by no later than June 25 at 4:00 p.m. ORDERED by Judge Leonard P. Stark on 6/23/21. (ntl)
Jun 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 1:20-cv-01332-LPS, 96 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Optimus Pharma Pvt. Ltd.). Signed by Judge Leonard P. Stark on 6/21/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01332-LPS (ntl)
Jun 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (97 in 1:19-cv-01938-LPS, 15 in 1:20-cv-01365-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation. Signed by Judge Leonard P. Stark on 6/21/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01365-LPS (ntl)
Jun 21, 2021	98	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Pilar G. Kraman regarding Request for the Court's Guidance as to its Preference for an In-Person or Virtual Markman Hearing on June 28, 2021. (Kraman, Pilar)
Jun 16, 2021	97	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Alembic Pharmaceuticals Ltd., et al.), by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Balick, Steven)
Jun 11, 2021	96	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Optimus Pharma Pvt. Ltd.) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jun 10, 2021	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' request (D.I. 94), IT IS HEREBY ORDERED that each side will have up to 45 minutes to present its position at the upcoming claim construction hearing. ORDERED by Judge Leonard P. Stark on 6/10/21. (ntl)
Jun 4, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected brief added to D.I. [92] per request of counsel. (ntl)
Jun 3, 2021	92	Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Balick, Steven) (Main Document 92 replaced on 6/4/2021) (ntl).
Jun 3, 2021	93	Main Document (12) Docket Text: APPENDIX re [92] Joint Claim Construction Brief by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit 1-24)(Balick, Steven)
Jun 3, 2021	93	Exhibit 1-24 (492)
Jun 3, 2021	94	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding the Parties' Joint Position Concerning Live Testimony and Duration of Markman Hearing. (Balick, Steven)
May 21, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [90] STIPULATION and [Proposed] Order Extending the Deadline for Substantial Completion of Document Production from May 17, 2021 Through and Including June 17, 2021 filed by MSN Laboratories Pvt. Ltd., Accord Healthcare Inc., MSN Pharmaceuticals Inc. Signed by Judge Leonard P. Stark on 5/21/21. (ntl)
May 14, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [91] MOTION for Pro Hac Vice Appearance of Attorney Eric Levi filed by Apotex Pharmachem Inc., Signa S.A. de C.V., Apotex Inc., Apotex Corp. Signed by Judge Leonard P. Stark on 5/14/21. (ntl)
May 14, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Eric Levi for Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
May 14, 2021	91	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Eric Levi - filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V.. (Francella, Thomas)
May 13, 2021	90	Stipulation (5) Docket Text: STIPULATION and [Proposed] Order Extending the Deadline for Substantial Completion of Document Production from May 17, 2021 Through and Including June 17, 2021 by Accord Healthcare Inc., MSN Laboratories Pvt. Ltd., MSN Pharmaceuticals Inc.. (Seaman, John)
May 5, 2021	89	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
May 3, 2021	87	Order (1) Docket Text: ORDER re [84] MOTION to Extend Certain Claim Construction Deadlines (UNOPPOSED) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 4/30/21. (ntl)
May 3, 2021	88	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1. Defendant Teva Pharmaceuticals USA, Inc.'s Responses and Objections to Plaintiffs Otsuka Pharmaceutical Co., Ltd., and H. Lundbeck A/S's First Set of Requests for the Production of Documents and Things (Nos. 1-40) 2. Defendant Teva Pharmaceuticals USA, Inc.'s Responses and Objections to Plaintiffs Otsuka Pharmaceutical Co., Ltd., and H. Lundbeck A/S's First Set of Interrogatories (Nos. 1-11) filed by Teva Pharmaceuticals USA Inc..(Hoeschen, Nathan)
Apr 30, 2021	N/A	Order Cancelling Deadline (0) Docket Text: ORAL ORDER: IT IS HEREBY ORDERED that the discovery teleconference scheduled for May 4, 2021 is CANCELLED. ORDERED by Judge Leonard P. Stark on 4/30/21. (ntl)
Apr 30, 2021	86	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Infringement Contentions filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Apr 29, 2021	84	Main Document (2) Docket Text: MOTION to Extend Certain Claim Construction Deadlines (UNOPPOSED) - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Text of Proposed Order)(Balick, Steven)
Apr 29, 2021	84	Text of Proposed Order (1)
Apr 26, 2021	82	Notice of Change of Address (1) Docket Text: NOTICE of Change of Address by Kenneth Laurence Dorsney (Dorsney, Kenneth)
Apr 26, 2021	83	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Kelly E. Farnan regarding Discovery Teleconference Scheduled for May 4, 2021 - re [81] Order Setting Teleconference,,,, [80] Letter. (Farnan, Kelly)
Apr 20, 2021	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER: After having been advised by Plaintiff(s) and Defendant(s) of their inability to resolve a discovery matter, IT IS HEREBY ORDERED that a teleconference is scheduled for May 4, 2021 at 11:45 a.m. The parties and any interested members of the public can access the teleconference by dialing 877-336-1829 and using the access code 1408971. IT IS FURTHER ORDERED that not later than April 28, 2021, any party seeking relief shall file with the Court a letter, not to exceed three (3) pages, outlining the issues in dispute and its position on those issues. Not later than April 30, 2021, any party opposing the application for relief may file a letter, not to exceed three (3) pages, outlining that party's reasons for its opposition. Should the Court find further briefing necessary upon conclusion of the telephone conference, the Court will order it. Alternatively, the Court may choose to resolve the dispute prior to the telephone conference and will, in that event, cancel the conference. ORDERED by Judge Leonard P. Stark on 4/20/2021. (ntl)
Apr 15, 2021	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jacqueline Genovese Bova for Teva Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Apr 14, 2021	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' joint proposal (D.I. 78) to modify the Scheduling Order (D.I. 34 14), IT IS HEREBY ORDERED that the parties shall notify the Court, by joint letter submission, no later than May 27, 2021, the date on which their joint claim construction brief is due: (i) whether they request leave to present testimony at the hearing; and (ii) the amount of time they are requesting be allocated to them for the hearing. ORDERED by Judge Leonard P. Stark on 4/14/21. (ntl)
Apr 14, 2021	80	Letter (2) Docket Text: Letter to The Honorable Leonard P. Stark from Kelly E. Farnan regarding Request Discovery Teleconference. (Farnan, Kelly)
Apr 13, 2021	78	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Steven J. Balick regarding All Parties' Request to Defer Submission of Correspondence Concerning Live Testimony at Markman Hearing and Duration of Hearing. (Balick, Steven)
Apr 8, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (12 in 1:20-cv-01335-LPS, 74 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Ajanta Pharma Ltd.). Signed by Judge Leonard P. Stark on 4/8/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01335-LPS (ntl)
Mar 31, 2021	77	Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [71] Amended Complaint, by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd..(Gaza, Anne)
Mar 30, 2021	76	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Unichem Laboratories Ltd.'s First Set of Interrogatories (Nos. 1- 10) and Plaintiffs' Objections and Responses to Unichem Laboratories Ltd.'s First Set of Requests for Admissions (Nos. 1- 10) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Mar 26, 2021	74	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Ajanta Pharma Ltd.), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Balick, Steven)
Mar 26, 2021	75	Notice of Appearance (1) Docket Text: NOTICE of Appearance by Bindu Ann George Palapura on behalf of Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd. (Palapura, Bindu)
Mar 23, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [73] STIPULATION TO EXTEND TIME deadline for the substantial completion of document production to May 17, 2021 filed by Alkem Laboratories Ltd. Signed by Judge Leonard P. Stark on 3/22/21. (ntl)
Mar 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [68] STIPULATION Seeking to Extend Certain Claim Construction Briefing Deadlines filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/18/21. (ntl)
Mar 19, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [72] STIPULATION Regarding Dismissal of Claims Against Certain Defendants Without Prejudice, and Amendment of Case Caption -- Party Amneal Pharmaceuticals, Inc., Amneal EU, Ltd. and Amneal Pharmaceuticals of New York terminated. Signed by Judge Leonard P. Stark on 3/18/21. (ntl)
Mar 19, 2021	73	Stipulation to EXTEND Time (5) Docket Text: STIPULATION TO EXTEND TIME deadline for the substantial completion of document production to May 17, 2021 - filed by Alkem Laboratories Ltd.. (Gattuso, Dominick)
Mar 18, 2021	72	Stipulation (5) Docket Text: STIPULATION Regarding Dismissal of Claims Against Certain Defendants Without Prejudice, and Amendment of Case Caption, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Mar 17, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [69] STIPULATION Seeking Leave to File First Amended Complaint filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/17/21. (ntl)
Mar 17, 2021	71	Main Document (21) Docket Text: AMENDED COMPLAINT against Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd., Amneal Pharmaceuticals, Inc., Amneal Pharmaceuticals of New York, Amneal EU, Ltd.- filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-G)(Balick, Steven)
Mar 17, 2021	71	Exhibit A-G (238)
Mar 17, 2021	71	Amended Complaint* (1)
Mar 16, 2021	69	Main Document (3) Docket Text: STIPULATION Seeking Leave to File First Amended Complaint, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit A, # (2) Exhibit B)(Balick, Steven)
Mar 16, 2021	69	Exhibit A (260)
Mar 16, 2021	69	Exhibit B (23)
Mar 16, 2021	70	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Balick, Steven)
Mar 11, 2021	68	Stipulation (5) Docket Text: STIPULATION Seeking to Extend Certain Claim Construction Briefing Deadlines, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Mar 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (13 in 1:20-cv-01502-LPS, 63 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Prinston Pharmaceutical). Signed by Judge Leonard P. Stark on 3/9/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01502-LPS (ntl)
Mar 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [64] STIPULATION and Order Dismissing Defendant MSN Life Sciences Pvt. Ltd. Without Prejudice and Amending Caption to Reflect Same -- Party MSN Life Sciences Pvt. Ltd. terminated. Signed by Judge Leonard P. Stark on 3/9/21. (ntl)
Mar 8, 2021	65	Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Otsuka Pharmaceutical's First Set of Common Interrogatories (Nos. 1-11) and 2) Zydus Pharmaceuticals (USA) Inc. and Cadila Healthcare Limited's Objections and Responses to Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-40) filed by Cadila Healthcare Ltd., Zydus Pharmaceuticals (USA) Inc..(Swadley, Beth)
Mar 8, 2021	66	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Ajanta Pharma Limiteds Objections and Responses to Plaintiffs First Set of Common Interrogatories to Ajanta (Nos. 1-11) and Defendant Ajanta Pharma Limiteds Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-40) filed by Ajanta Pharma Ltd..(Stamoulis, Stamatios)
Mar 8, 2021	67	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Common Interrogatories to Ajanta (Nos. 1-11) and Defendant Optimus Pharma Pvt. Ltd.s Objections and Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-40) filed by Optimus Pharma Pvt. Ltd..(Stamoulis, Stamatios)
Mar 5, 2021	63	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation (Prinston Pharmaceutical), by H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Mar 5, 2021	64	Stipulation (5) Docket Text: STIPULATION and Order Dismissing Defendant MSN Life Sciences Pvt. Ltd. Without Prejudice and Amending Caption to Reflect Same by MSN Laboratories Pvt. Ltd., MSN Life Sciences Pvt. Ltd., MSN Pharmaceuticals Inc.. (Seaman, John)
Mar 2, 2021	62	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Amneal's Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-40), and 2) Defendant Amneal's Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-11) filed by Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Raks Pharma Pvt. Ltd..(Vrana, Robert)
Feb 24, 2021	59	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Unichem Laboratories, Ltd.s First Set of Interrogatories to Plaintiffs (Nos. 1-9) and (2) Defendant Unichem Laboratories, Ltd.s First Set of Requests for Admissions to Plaintiffs (Nos.1-10) filed by Unichem Laboratories Ltd..(Delcollo, Renee)
Feb 24, 2021	60	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Responses and Objections to Plaintiffs' First Set of Requests for Production of Documents and Things (Nos. 1-40); and Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc.'s Responses and Objections to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-11) filed by Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Ltd..(Palapura, Bindu)
Feb 24, 2021	61	Notice of Service (2) Docket Text: NOTICE OF SERVICE of 1) Defendant Sandoz Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-40) and 2) Defendant Sandoz Inc.'s Objections and Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-11) filed by Sandoz Inc..(Vrana, Robert)
Feb 22, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (48 in 1:19-cv-01938-LPS, 16 in 1:20-cv-01423-LPS) STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 2/22/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01423-LPS (ntl)
Feb 22, 2021	51	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Hetero's responses to Plaintiffs' First Set of Interrogatories (Nos. 1-11); (2) Hetero's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-40); (3) Biophore and Zenara's responses to Plaintiffs' First Set of Interrogatories (Nos. 1-11); and (4) Biophore and Zenara's responses to Plaintiffs' First Set of Requests for Production (Nos. 1-40) filed by Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Feb 22, 2021	52	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Aurobindo's responses to first set of common interrogatories and (2) Aurobindo's responses to first set of requests for production filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc..(Dorsney, Kenneth)
Feb 22, 2021	53	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Macleods' Responses to Plaintiffs' First Set of Common Interrogatories (Nos. 1-11) and; (2) Macleods' Responses to Plaintiffs' First Set of Requests for Production (No. 1-40) filed by Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd..(Dorsney, Kenneth)
Feb 22, 2021	54	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Unichem Laboratories Ltd.s Answers to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-11) and (2) Defendant Unichem Laboratories Ltd.s Responses to Plaintiffs First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-40) filed by Unichem Laboratories Ltd..(Farnan, Kelly)
Feb 22, 2021	55	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) MSN's Objections and Responses to Otsuka's First Set of Requests for Production (Nos. 1-40) and (ii) MSN's Objections and Responses to Otsuka's First Set Of Interrogatories (Nos. 1-11) filed by MSN Laboratories Pvt. Ltd., MSN Life Sciences Pvt. Ltd., MSN Pharmaceuticals Inc..(Seaman, John)
Feb 22, 2021	56	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (i) Accord's Objections and Responses to Otsuka's First Set of Requests for Production (Nos. 1-40) and (ii) Accord's Objections and Responses to Otsuka's First Set of Interrogatories (Nos. 1-11) filed by Accord Healthcare Inc..(Seaman, John)
Feb 22, 2021	57	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Alkem Laboratories Ltd.'s (i) Answers and Objections to Plaintiffs' First Set of Common Interrogatories (Nos. 1-11); and (ii) Answers and Objections to Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-40) filed by Alkem Laboratories Ltd..(Gattuso, Dominick)
Feb 22, 2021	58	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Objections and Responses to Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-40); and (2) Defendants Apotex Inc., Apotex Corp., Apotex Pharmachem Inc. and Signa S.A. de C.V.'s Objections and Responses to Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-11) filed by Apotex Corp., Apotex Inc., Apotex Pharmachem Inc., Signa S.A. de C.V..(Francella, Thomas)
Feb 19, 2021	50	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Prinstons Objections and Responses to Plaintiffs First Set of Common Interrogatories to Defendants (Nos. 1-11) and (2) Prinstons Objections and Responses to Plaintiffs First Set of Requests to Defendant for the Production of Documents and Things (Nos. 1-40) filed by Prinston Pharmaceutical Inc..(Stamoulis, Stamatios)
Feb 18, 2021	49	Main Document (12) Docket Text: CLAIM Construction Chart by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit 1-9)(Mayo, Andrew)
Feb 18, 2021	49	Exhibit 1-9 (133)
Feb 17, 2021	48	Stipulation (5) Docket Text: STIPULATION Regarding Partial Dismissal of Claims and Counterclaims, and Regarding Consolidation, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Feb 16, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [46] STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Joint Claim Construction Chart filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 2/16/21. (ntl)
Feb 12, 2021	47	Notice (Other) (2) Docket Text: NOTICE of of Change of Law Firm Affiliation by Ajanta Pharma Ltd., Optimus Pharma Pvt. Ltd. (Stamoulis, Stamatios)
Feb 11, 2021	46	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Joint Claim Construction Chart, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Feb 10, 2021	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-01423-LPS, 45 in 1:19-cv-01938-LPS) MOTION for Pro Hac Vice Appearance of Attorney Jacqueline Genovese Bova filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc. Signed by Judge Leonard P. Stark on 2/10/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01423-LPS (ntl)
Feb 9, 2021	45	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jacqueline Genovese Bova - filed by Teva Pharmaceuticals USA Inc., Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan)
Jan 29, 2021	44	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Proposed Claim Terms and Constructions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Jan 22, 2021	N/A	CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Corrected document added to D.I. 43 per request of counsel. (ntl)
Jan 21, 2021	43	Notice of Service (5) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests to Defendants for the Production of Documents and Things (Nos. 1-40) and Plaintiffs' First Set of Common Interrogatories to Defendants (Nos. 1-11) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew) (Main Document 43 replaced on 1/22/2021) (ntl).
Dec 28, 2020	42	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Joint Invalidity Contentions filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Zydus Pharmaceuticals (USA) Inc..(Dorsney, Kenneth)
Dec 21, 2020	41	Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories (Nos. 1-5) and Plaintiffs' Responses to Defendants' First Set of Common Requests for the Production of Documents and Things (Nos. 1-74) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Nov 20, 2020	40	Notice of Service (6) Docket Text: NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Nov 19, 2020	39	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-5); and (2) Defendants' First Set of Common Requests for Production to Plaintiffs (Nos. 1-74) filed by Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., Biophore India Pharmaceuticals Private Ltd., Hetero Drugs Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-V, Hetero USA Inc., Honour Lab Ltd., Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Nov 18, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [38] Stipulated Protective Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/17/20. (ntl)
Nov 13, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Aryeh N. Feinstein for Lupin Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam)
Nov 13, 2020	38	Proposed Order (30) Docket Text: PROPOSED ORDER (Stipulated Protective Order) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Nov 12, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [37] MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein filed by Lupin Pharmaceuticals Inc., Lupin Limited. Signed by Judge Leonard P. Stark on 11/12/20. (ntl)
Nov 11, 2020	37	Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Aryeh N. Feinstein - filed by Lupin Limited, Lupin Pharmaceuticals Inc.. (Attachments: # (1) Certification of Aryeh N. Feinstein)(Bilson, David)
Nov 11, 2020	37	Certification of Aryeh N. Feinstein (1)
Nov 6, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [36] STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 11/6/20. (ntl)
Nov 5, 2020	36	Stipulation (5) Docket Text: STIPULATION Seeking to Extend the Deadline by which the Parties Must Submit a Proposed Protective Order, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Oct 23, 2020	N/A	Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak)
Oct 23, 2020	34	Scheduling Order (23) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. All actions are consolidated into lead action no. 19-1938-LPS and all filings shall be made in the lead action only. Fact Discovery completed by 9/3/2021. Status Report due by 9/15/2021. Joint Claim Construction Brief due by 5/27/2021. A Markman Hearing is set for 6/28/2021 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. Proposed Pretrial Order due by 7/1/2022. A Final Pretrial Conference is set for 7/8/2022 at 09:00 AM in Courtroom 6B before Judge Leonard P. Stark. A 7-day Bench Trial is set for 7/25/2022 at 08:30 AM in Courtroom 6B before Judge Leonard P. Stark. Signed by Judge Leonard P. Stark on 10/19/20. (ntl)
Oct 23, 2020	N/A	Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Counsel are to advise on or before 11/13/20 by a JOINT EMAIL to Judge Thynge, with a copy to her Judicial Administrator, Ms. Kennedy, their clients interest in mediation and the timing when mediation is preferred with a very brief explanation why. When referencing the timing for mediation, counsel rely on certain events in the scheduling order, for example, before claim construction briefing, after the close of discovery, before expert reports and the like, they are to include the date(s) on when such event(s) occur. Ordered by Chief Magistrate Judge Mary Pat Thynge on 10/23/20. (cak)
Oct 16, 2020	31	Letter (1) Docket Text: Letter to The Honorable Leonard P. Stark from Andrew C. Mayo regarding revised schedule following October 2, 2020 status conference. (Mayo, Andrew)
Oct 16, 2020	32	Proposed Order (25) Docket Text: PROPOSED ORDER (Proposed Scheduling Order) by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Oct 16, 2020	33	Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery; (2) Plaintiffs' Initial Disclosures Pursuant to Paragraph 4(a) of the Default Standard for Discovery; and (3) Plaintiffs' Initial Disclosure Statement Pursuant to Fed. R. Civ. P. 26(a)(1) filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd..(Mayo, Andrew)
Oct 5, 2020	28	Transcript (35) Docket Text: Official Transcript of Telephone Conference held on October 2, 2020 before Chief Judge Leonard P. Stark. Court Reporter Brian Gaffigan, e-mail: Brian_Gaffigan@ded.uscourts.gov. Transcript may be viewed at the court public terminal or ordered and purchased through the Court Reporter before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 10/26/2020. Redacted Transcript Deadline set for 11/5/2020. Release of Transcript Restriction set for 1/4/2021. (bpg)
Oct 5, 2020	29	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Zenara and Biophore's core technical documents filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Oct 5, 2020	30	Notice Requesting Removal of Co-Counsel (7) Docket Text: NOTICE requesting Clerk to remove Douglas W. Cheek as co-counsel. Reason for request: no longer with firm. (Mayo, Andrew)
Oct 2, 2020	N/A	Telephone Conference (0) Docket Text: Minute Entry for proceedings held before Judge Leonard P. Stark - Telephone Conference held on 10/2/2020. (Court Reporter B. Gaffigan.) Associated Cases: 1:19-cv-01938-LPS et al. (ntl)
Oct 2, 2020	N/A	Order (0) Docket Text: ORAL ORDER: Having reviewed the parties' joint status report (D.I. 26) and for the reasons stated on the October 2, 2020 teleconference IT IS HEREBY ORDERED that the Rule 12(c) motions filed in these consolidated cases concerning non-infringement of the '419 formulation patent are DENIED WITHOUT PREJUDICE. (See C.A. No. 19-1956, D.I. 15; C.A. No. 19-2008, D.I. 12; C.A. No. 19-1938, D.I. 12; C.A. No. 19-1954, D.I. 26). IT IS HEREBY FURTHER ORDERED that the parties shall submit a revised proposed scheduling order, not later than two weeks from today, consistent with the Court's rulings. ORDERED by Judge Leonard P. Stark on 10/2/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl)
Sep 30, 2020	26	Main Document (21) Docket Text: Joint STATUS REPORT by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Attachments: # (1) Exhibit 1-3)(Balick, Steven)
Sep 30, 2020	26	Exhibit 1-3 (131)
Sep 28, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Tyler B. Latcham,James B. Monroe for H. Lundbeck A/S, for Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 19-cv-02065-LPS,19-cv-01956-LPS, 19-cv-01952-LPS, 19-cv-02008-LPS, 19-cv-01964-LPS,19-cv-02009-LPS, 19-cv-01987-LPS, 19-cv-01954-LPS,19-cv-01965-LPS,19-cv-01955-LPS, 19-cv-02007-LPS, 19-cv-01938-LPS, 19-cv-01939-LPS, 19-cv-02024-LPS,19-cv-01988-LPS, 19-cv-01977-LPS, 19-cv-02080-LPS,19-cv-02006-LPS (myr)
Sep 14, 2020	N/A	Order Setting Teleconference (0) Docket Text: ORAL ORDER: Having reviewed the dockets in these multiple related matters, and having noted that there are pending motions in some but not all (and some of the motions appear to present similar if not identical issues), IT IS HEREBY ORDERED that the parties shall meet and confer and, no later than September 30, submit a joint status report advising the Court of how they propose the Court proceed in each of these matters. IT IS FURTHER ORDERED that the Court will hold a joint status teleconference in all of these matters on October 2 and 12:00 p.m. The parties shall use the following dial-in information: 877-336-1829 and using the access code 1408971. ORDERED by Judge Leonard P. Stark on 9/14/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl)
Sep 8, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Denise Main for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd)
Sep 4, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney C. Collette Corser for H. Lundbeck A/S,for Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr)
Jul 23, 2020	24	Notice of Service (2) Docket Text: NOTICE OF SERVICE of Rule 26(a) disclosures and paragraph 3 disclosures filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Jun 12, 2020	23	SO ORDERED (2) Docket Text: SO ORDERED, re [20] MOTION to Seal Document: [19] Reply Brief, in support of Motion for Leave to File Motion for Judgment on the Pleadings of Noninfringement of the '419 Patent (UNOPPOSED) filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. Signed by Judge Leonard P. Stark on 6/12/20. (ntl)
Jun 11, 2020	22	Redacted Document (30) Docket Text: REDACTED VERSION of [19] Reply Brief, in support of MOTION for Leave to file Motion for Judgment on the Pleadings of Noninfringement of the '419 Patent by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Jun 5, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [16] STIPULATION Seeking to Permit Plaintiffs to File Answering Brief Under Seal filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 6/4/20. (ntl)
Jun 4, 2020	20	Motion to Seal Document (2) Docket Text: MOTION to Seal Document: [19] Reply Brief, in support of Motion for Leave to File Motion for Judgment on the Pleadings of Noninfringement of the '419 Patent (UNOPPOSED) - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Jun 4, 2020	21	Redacted Document (30) Docket Text: REDACTED VERSION of [17] Answering Brief in Opposition, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jun 3, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Douglas W. Cheek for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd)
Jun 1, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (17 in 1:19-cv-02024-LPS, 12 in 1:19-cv-01977-LPS, 17 in 1:19-cv-01952-LPS, 13 in 1:19-cv-01964-LPS, 14 in 1:19-cv-01956-LPS, 14 in 1:19-cv-01988-LPS, 11 in 1:19-cv-02008-LPS, 18 in 1:19-cv-01938-LPS, 15 in 1:19-cv-01955-LPS, 14 in 1:19-cv-02007-LPS, 12 in 1:19-cv-02009-LPS, 12 in 1:19-cv-01939-LPS, 11 in 1:19-cv-02065-LPS, 13 in 1:19-cv-02006-LPS, 12 in 1:19-cv-01965-LPS, 23 in 1:19-cv-01954-LPS, 15 in 1:19-cv-02080-LPS, 14 in 1:19-cv-01987-LPS) MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 6/1/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl)
May 29, 2020	18	Motion for Leave to Appear Pro Hac Vice (14) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas W. Cheek - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
May 28, 2020	16	Stipulation (2) Docket Text: STIPULATION Seeking to Permit Plaintiffs to File Answering Brief Under Seal, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
May 21, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION to Seal Document: [13] Opening Brief in Support (UNOPPOSED) filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. Signed by Judge Leonard P. Stark on 5/19/20. (ntl)
May 19, 2020	15	Redacted Document (30) Docket Text: REDACTED VERSION of [13] Opening Brief in Support, of Defendants Zenara and Biophore's Motion for Leave to file Motion for Judgment on the Pleadings of Noninfringement of the '419 Patent by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
May 15, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Dmitry V. Shelhoff for Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
May 14, 2020	12	Motion for Miscellaneous Relief (3) Docket Text: MOTION for Leave to file Motion for Judgment on the Pleadings of Noninfringement of the '419 Patent - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
May 14, 2020	14	Motion to Seal Document (2) Docket Text: MOTION to Seal Document: [13] Opening Brief in Support, (UNOPPOSED) - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Apr 23, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Erin M. Sommers for H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-01938-LPS et al.(kmd)
Apr 9, 2020	N/A	Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kenneth S. Canfield and Edward D. Pergament for Biophore India Pharmaceuticals Private Ltd. and Zenara Pharma Private Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
Apr 7, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [11] MOTION for Pro Hac Vice Appearance of Attorney Edward D. Pergament and Attorney Kenneth S. Canfield filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. Signed by Judge Leonard P. Stark on 4/7/20. (ntl)
Apr 6, 2020	11	Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Edward D. Pergament and Attorney Kenneth S. Canfield - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Mar 5, 2020	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re (8 in 1:19-cv-02065-LPS, 9 in 1:19-cv-01956-LPS, 13 in 1:19-cv-01952-LPS, 9 in 1:19-cv-02008-LPS, 9 in 1:19-cv-01964-LPS, 8 in 1:19-cv-02009-LPS, 12 in 1:19-cv-01987-LPS, 21 in 1:19-cv-01954-LPS, 8 in 1:19-cv-01965-LPS, 10 in 1:19-cv-01955-LPS, 8 in 1:19-cv-02007-LPS, 10 in 1:19-cv-01938-LPS, 10 in 1:19-cv-01939-LPS, 10 in 1:19-cv-02024-LPS, 11 in 1:19-cv-01988-LPS, 11 in 1:19-cv-01977-LPS, 10 in 1:19-cv-02080-LPS, 10 in 1:19-cv-02006-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, Tyler B. Latcham, and C. Collette Corser filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 3/5/20. Associated Cases: 1:19-cv-01938-LPS et al. (ntl)
Mar 2, 2020	10	Motion for Leave to Appear Pro Hac Vice (18) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, Tyler B. Latcham, and C. Collette Corser - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Oct 30, 2019	8	Answer to Complaint (17) Docket Text: ANSWER to [1] Complaint, by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd..(Dorsney, Kenneth)
Oct 30, 2019	9	Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Biophore India Pharmaceuticals Private Ltd. for Zenara Pharma Private Ltd. filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Oct 24, 2019	N/A	SO ORDERED (0) Docket Text: SO ORDERED, re [7] MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. Signed by Judge Leonard P. Stark on 10/24/19. (ntl)
Oct 23, 2019	7	Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Dmitry V. Shelhoff - filed by Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd.. (Dorsney, Kenneth)
Oct 16, 2019	N/A	Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:19-cv-01938-LPS, 1:19-cv-01939-LPS (rjb)
Oct 15, 2019	N/A	No Summons Issued (0) Docket Text: No Summons Issued. (nmg)
Oct 11, 2019	1	Main Document (18) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Biophore India Pharmaceuticals Private Ltd., Zenara Pharma Private Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2753708.) - filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. (Attachments: # (1) Exhibit A-G, # (2) Civil Cover Sheet)(nmg)
Oct 11, 2019	1	Exhibit A-G (239)
Oct 11, 2019	1	Civil Cover Sheet (2)
Oct 11, 2019	2	Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
Oct 11, 2019	3	ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/6/2019. Date of Expiration of Patent: See Attached. (nmg)
Oct 11, 2019	4	Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,888,362; 8,349,840; 8,618,109; 9,839,637; 10,307,419. (nmg)
Oct 11, 2019	5	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. filed by Otsuka Pharmaceutical Co., Ltd. (nmg)
Oct 11, 2019	6	Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by H. Lundbeck A/S. (nmg)
Oct 11, 2019	1	Complaint* (1)

Lawsuits

Otsuka Pharmaceutical Co., Ltd. et al v. Zenara Pharma Private Ltd. et al > Documents